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INTRODUCTION
GENERAL
The mind of man sets man apart. Yet our 
knowledge of the physiology and biochemistry of the 
organ of the mind, the brain, remains scanty. There 
seems to be little doubt, however, that the extreme 
complexity and the many unknown factors in brain 
function create a fascination in the study of the central 
nervous system. For the pharmacologist, the study of 
the way in which drugs modify brain function presents 
no less a challenge. Indeed, drugs have been used 
from time immemorial to induce temporary aberrations of 
the mind. For example, peyote, the most active alkaloid 
of which is mescaline, has been used for centuries by 
the Kiowa Indians of North America to Induce central 
nervous system stimulation and visual hallucinations 
during religious ceremonies (Osol & Farrar, 1955).
It is well known that man has for centuries used coffee 
and tea containing caffeine, coca leaves containing 
cocaine, tobacco containing nicotine and beverages 
containing alcohol to modify his mood for social 
pleasure or to enhance his performance under stress.
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Many of these naturally occurring drugs, notably 
caffeine, nicotine and alcohol, are still widely 
used, but as well, a large armamentarium of synthetic 
compounds is now at the disposal of the clinician. 
Although many of these synthetic compounds have found 
wide application for the relief of the symptoms of 
mental disorders, their use has extended beyond 
psychiatric hospitals into general medical practice 
where large quantities are now prescribed. Yet. for 
most, if not all of these drugs, the precise mechanism 
of action is unknown. It is not only the lack of 
knowledge of the mode of action of the drugs themselves, 
but also the fundamental lack of understanding of normal 
brain function and of the aetiology of mental Illness, 
the symptoms of which certain drugs can so markedly 
affect, that commands research to be continued and indeed 
expanded in this field of endeavour.
This thesis is concerned primarily with an 
attempt to find out more about: the effects of three 
groups of central nervous stimulant drugs on some aspects 
of the biochemistry of the brain in the hope that such 
information may eventually lead to a fuller understanding 
of the way in which these drugs act. For clarity, it
- 3 -
should he pointed out that in this thesis the phrase 
"central nervous system stimulant drugs" is taken to 
include those drugs which primarily affect the 
functioning of the higher centres of the hrain and in 
general produce elevation of the mood, euphoria, 
increased motor activity and decreased sleeping time.
This group forms part of the large general group of 
"psychotropic drugs" which have been defined as 
"compounds having a pharmacodynamic effect on the 
higher functions of the central nervous system"
(Jacobsen, 1959). The phrase "central nervous system 
stimulant drugs" is thus intended to exclude those drugs 
such as picrotoxin, leptazole, nikethamide, 
pentamethylenetetrazole and strychnine which markedly 
affect the lower parts of the central nervous system, 
induce convulsions and are used primarily as analeptics. 
As will be seen in the ensuing discussion of thèir 
development (see pages 5 - 1 3  ), synthetic central 
nervous system stimulant drugs fall into three main 
groups depending on certain differences in their chemical 
structure and pharmacological and biochemical effects.
The first group comprises amphetamine and drugs which 
resemble it in their pharmacological actions
- - 4  -
(e.g. methylphenidate, pipradrol, phenmetrazine) and 
are called "the amphetamine-like central nervous system 
stimulants". The members of the second group 
(e.g. iproniazid, phenelzine, tranyleypropmine, 
pheniprazine) are characterized by the fact that they 
are potent inhibitors of the enzyme monoamine oxidase 
in vitro and ^  vivo and are referred to as "the 
monoamine oxidase inhibitors". The drugs of the third 
group (e.g. imipramine, amitrj:ptyline) are characterized 
both by their ability to alleviate the symptoms of 
certain types of depression and by their chemical 
similarity to phenothiazine and are called "the 
antidepressives resembling phenothiazine in chemical 
structure". This nomenclature is derived from the 
recent classification of psychotropic drugs described 
by Shepherd and Vfing (1962) which was based on the 
suggestions of the World Health Organization Study 
Group (1958), A number of other classifications have 
been proposed (see Kletzkin, 1962 and references cited), 
but as Shepherd and Wing (1962) have pointed out with 
regard to psychotropic drugs, "the data derived from 
current methods of study do not delineate their actions 
clearly enough for anything but a provisional system
— 5 —
of classification". The advantages and disadvantages 
of the different systems of classification are not, 
therefore, discussed here, and the provisional 
nomenclature used has been set down only as an aid 
to: further discussion in this thesis.
The Development of Synthetic Central Nervous System 
Stimulants.
The history of the development of synthetic 
drugs which stimulate the higher centres of the 
central nervous system has been characterized by the 
fact that,in many cases, they were synthesized in an 
attempt to find compounds with an entirely different 
pharmacological action or as part of more general 
studies on the relationship between chemical structure 
and pharmacological action. The appreciation of the 
clinical value of central nervous system stimulants 
often came only after considerable investigation 
of their other properties, and studies designed 
primarily to find new drugs for the treatment of mental 
depression are of recent origin.
Thus, the first synthetic central nervous 
system stimulants were discovered during the intense 
studies of the peripheral sympathetic nervous system
- 6 -
at the beginning of the present century. The 
observation that extracts of the adrenal medulla 
possessed a vasopressor action (Oliver & Schafer, 1895) 
quickly led to the elucidation of the chemical structure 
of the active principle, adrenaline, largely through 
the efforts of Abel and Crawford (1897, 1899), 
v.Purth (1900) and Takamine (1901), and to its synthesis 
independently and almost simultaneously by Stolz (1904) 
and Dakln (1905a). The apparent discrepancy between 
the conclusion that the catechol nucleus was essential 
for adrenaline-like activity (Dakin, 1905b) and 
observations that amines lacking this group had an 
adrenaline-like action (Barger & Dale, 1910), pro^ipted 
the investigation, by the latter workers, into the 
relationship between the chemical structure and the 
pharmacological action of a series of aliphatic and 
aromatic amines. Since these compounds were found to 
"simulate the effects of sympathetic nerves not only 
with varying intensity but with varying precision", 
the term "sympathomimetic^* was introduced to describe
their pharmacological action (Barger & Dale, 1910), 
Although the ability of certain sympathomimetic drugs, 
including ephedrine, to arouse chloral hydrate-
- 7 -
anaesthetized rabbits was studied as early as 1913 
(Airila), a marked awareness of and interest in their 
central stimulant actions was not forthcoming until 
some twenty years later. Even then, the investigation 
of the vasopressor action of amphetamine (Piness,
Miller & Allés, 1930) preceded by three years the first 
mention of its analeptic and respiratory stimulant 
properties (Allés, 1933). Considerable interest was, 
however, subsequently shown in the central stimulant 
properties of amphetamine and attempts were soon made 
to use it for the relief of the symptoms of narcolepsy 
(Prinzmetal & Bloomberg, 1935) and postencephalitic 
Parkinsonism (Solomon, Mitchell & Prinzmetal, 1937).
The extensive review by Ivy and Krasno (1941) on 
the clinical application of the central stimulant 
properties of amphetamine cites many attempts to use 
this drug to treat various types of depression, to 
elevate the mood in different types of fatigue and 
to increase the willingness and capacity to work. 
Similarly, the closely related compound, methyl- 
amphetamine, prepared by Ogata in 1919, received 
little attention until 1938 when It was claimed that 
its central stimulant and euphoric effects could be
- 8 .
produced without undesirable side reactions (see Ivy 
& Goetzl, 1943 and references cited).
The first systematic investigation of the 
central stimulant properties of sympathomimetic amines 
in experimental animals was carried out in 1941 when 
a study was made of the quantitative effects of 
seventy-five amines on the spontaneous activity of 
unrestrained, un-narcotized rats (Schulte, Reif,
Bacher, Lawrence & Talnter, 1941). It was reported 
that the phenylisopropylamines (in particular 
^dextro-amphetamine) were particularly effective 
compounds with regard to minimum effective dosage, 
degree of stimulation, and intensity of effect per 
milligram of amine. In spite of the intensity and 
scope of this study, more than ten years were to elapse 
before new amphetamine-like central nervous system 
stimulants were to appear, and even then, they arose 
from studies not primarily designed to find new central 
nervous system stimulants.
Thus, although the compound methylphenidate was 
synthesized in 1944 by Panizzon during the investigation 
of a group of piperidine acetic acid esters, and 
pipradrol was synthesized in 1948ihy Tilford, Shelton
- 9 -
and Van Campen in a search for new antihistaininic 
agents, their central stimulant properties were not 
described until 1954. Me thylphenidate was then
observed to produce central nervous system stimulation 
in experimental animals similar to, but not identical 
with, amphetamine (Meier, Gross & Tripod, 1954).
Similarly pipradrol was reported to produce central 
nervous system stimulation but the effects were said to 
be qualitatively different from those of amphetamine 
(Brown & Wemer, 1954). Also at this time phenmetrazine 
(Thoma & Wick, 1954) was synthesized and six years later 
phendimetrazine appeared (Stegen, Zsoter, Tom & Chappel, 
1960). Although both of these compounds have been 
used as anorexigenic agents, they also produce considerable 
central nervous system stimulation (Stegen 1960;
Garberg & Sandberg, 1960; Knoll, 1961). Thus several 
new compounds with a central stimulant action similar 
to amphetamine, but different from it and from one 
another chemically, were discovered.
The period from 1952 to 1960 also witnessed 
the emergence of another group of central nervous 
system stimulant drugs whose pharmacological activity
—  10 —
also differed somewhat from amphetamine and its 
congeners. The observation that the hydrazine 
derivative iproniazid, initially introduced as an 
antitubercular drug (Pox & Gibas, 1953), also induced 
euphoria and stimulation in patients with tuberculosis 
(Selikoff, Robitzek & Ornstein, 1952), resulted in its 
clinical trial for the treatment of depression (Loomer, 
Saunders & Kline, 1957). Although first reports of 
the clinical effectiveness of iproniazid for the treatment 
of depression were enthusiastic, later judgments were 
more cautious (Rees & Benaim, 1959) and toxic side 
effects, the most serious being liver damage (Zimmerman, 
Rosenblum, Korn & Feldman, 1959), were reported. 
Nevertheless, the investigation of the wider aspects of 
the pharmacology of iproniazid, especially its ability 
to inhibit monoamine oxidase (Zeller, Barsky. Pouts, 
Kirchheimer & Van Orden, 1952; Zeller & Barsky, 1952), 
resulted in the synthesis of a large number of chemically 
and pharmacologically similar compounds (see Zeller,
1959, editor, symposium on amine oxidase inhibitors).
Indeed, in recent years a primary criterion for the 
selection of drugs for further investigation for the 
treatment of mental depression has been their ability
-  1 1  -
to block monoamine oxidase _în vitro and 3^ vivo 
(Burns & Shore, 1961). Among the large number of 
compounds which have been shown to inhibit monoamine 
oxidase, phenelzine, pheniprazine, isocarboxazid, 
nialamide and tranylcypromine (Chessin, Dubnick, Leeson 
& Scott, 1959; Horita, 1958; Randall & Bagdon, 1959;
Rowe, Bloom, P*an & Finger, 1959; Tedeschi, Tedeschi,
Ames, Cook, Mattis & Fellows, 1959; respectively) may 
be cited as examples of some of the compounds of this 
type which have also been reported to be of use in the 
treatment of depression (Holt, Wright & Hecker, 1960; 
Crisp, Hays & Carter, 1961; Dally & Rohde, 1961).
On the other hand, certain compounds have been 
found which show little or no ability to inhibit 
monoamine oxidase, but are, nevertheless, clinically 
useful for the treatment of certain types of depression. 
From a group of tertiary-aminoalkyliminodibenzyl 
derivatives synthesized in 1951, which had antihistaminic, 
antispasmodic and local anaesthetic actions (Hafliger 
& Schindler, 1951; Schindler & Hafliger, 1954), the 
compound imipramine was later shown to have anti- 
depressive properties (Kuhn, 1957). Pharmacologically,
— 12 —
Imlpramlne differs from the central nervous system 
stimulants previously mentioned because it does not 
tend to produce obvious signs of stimulation in normal 
animals (Domenjoz & Theobald, 1959). Instead, as 
these workers reported, it tends to resemble the 
tranquillizer chlorpromazine in that it exerts a 
taming effect on aggressive behaviour in experimental 
animals, reduces body temperature and potentiates 
hypnotics. Since imipramine only tends to produce 
signs of central nervous stimulation in animals 
sedated with a drug such as reserpine or in mentally 
depressed patients (Sulser, Watts & Brodie, 1962), it 
has been considered to represent a milestone in the 
development of drugs specifically for the treatment of 
mental disease and points out the need for new screening 
techniques to find such drugs. More recently, the 
chemically related compound amitrypty1ine (Freed, 1960), 
and the metabolite of imipramine, de smethyl imipr amine 
(Sulser et al., 1962), have also been claimed to be 
useful in alleviating the symptoms of certain types 
of depression.
Despite the rapidity with which synthetic
—  13 —
central nervous system stimulants have appeared in 
recent years, and the value of many of them in the 
treatment of various types of depression, their 
precise mechanism of action remains obscure. The 
now considerable research on these drugs has been 
concerned both with the physiological and biochemical 
aspects of their central action. Although the 
results of these two experimental approaches are no 
doubt related to one another, the various theories 
arising from them, which attempt to explain the 
mechanism of action of central nervous system 
stimulant drugs, can be conveniently considered 
separately.
- 14 -
THEORIES ON THE MEGHMISM OF ACTION OF CENTRAL 
NERVOUS SYSTEM STIMLANT DRUGS
Physiological Aspects 
Neurophysiological experiments, relying 
mainly upon macroelectrode techniques, have been 
carried out in an attempt to establish the site or 
sites of action of stimulant and depressant drugs 
within the brain. Among central stimulant drugs, 
considerable attention has been devoted to studies of 
the effect of amphetamine on the electrical activity 
of the brain (see reviews by Toman & Davis, 1949; 
Leake, 1958; Himwich, 1959).
Although a detailed review of the physiology 
of the central nervous system is outside the scope 
of this thesis, for clarity, a brief resume of the 
physiology of those areas of the brain believed to be 
implicated in the action of central stimulants will 
be given. Birzis (1960) considers that the closely 
related reticular activating system, the unspecific 
thalamocortical system and the limbic system may all 
be involved in the action of central nervous system
— 15 -
stlimilant drugs.
Among its other Important functions, the 
reticular activating system, consisting of the 
reticular formation and related thalamic nuclei, is 
implicated in governing the state of wakefulness 
(see review by French, 1960). In the sleeping or 
drowsy animal, high frequency stimulation (100 to 
200 per second) of the midbrain reticular formation 
or its afferent pathways gives rise to the appearance 
of low amplitude fast waves in the electroencephalogram 
(EEG) of the cortex. This EEG arousal pattern is 
normally associated with behavioural signs of 
awakening or alertness (Birzis, 1960). For the 
evaluation of the effects of drugs, either the 
thresholds at which EEG and behavioural arousal are 
produced, or the duration of the post-stimulatory 
excitation resulting from a constant maximal stimulus , 
may be used as test parameters.
The unspecific thalamocortical system consists 
of the rostral portions of the ascending reticular 
activating system of the brain and a diffuse network 
with connections to many parts of the cortex. It is
- 16 -
believed to mediate and distribute, to almost all 
parts of the cortex, some of the activation 
originating in the more caudal portions of the brain 
stem reticular formation. It may also serve to 
maintain a more direct control over the rhythmic 
electrical activity of the cortex and may act as an 
intrathalamic integrating system (Jasper, 1960 and 
references cited). Low frequency stimulation 
(5 to>15 per second) of the unspecific thalamocortical 
system produces the recruiting response in the cortex 
(Morrison & Dempsey, 1942) and this EEG pattern has 
been compared to the spindle bursts seen in barbiturate 
anaesthesia and to the resting alpha rhythm of the 
human EEG. Although there seems to be a reciprocal 
relationship between the recruiting response produced 
by the appropriate stimulation of the unspecific 
thalamocortical system and the alerting response 
produced by the appropriate stimulation of the reticular 
activating system (Tissot & Monnier, 1959), it is 
possible to elicit either response by stimulation of
a suitable locus in the rostral reticular formation 
where the two systems intermingle.
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The llmhic system is believed to consist 
of cortical structures such as the hippocampus, the 
cingulate gyrus, and entorhinal cortex, and also of 
subcortical masses such as the septum, amygdala, 
certain diencephalic nuclei, and connecting tracts 
(Birzis, I960). Although the limbic system is 
believed to be involved in emotion and perhaps as a 
modulator of the other systems, neither its precise 
functions (see reviews by Brady, 1960; Green, 1960; 
Gloor, 1960) nor its anatomical definition (Brady, 1960) 
have been clearly established.
Attempts to elucidate the site of action of 
central nervous system stimulant drugs have been made 
by studying their effects on the electrical activity 
in any one or all three of these systems. Although 
stimulant drugs generally convert the EEG to a fast, 
low-voltage pattern similar to that seen in the alert 
behavioural state, this effect seems to be produced 
in different ways.
Thus amphetamine lowers the threshold for 
production of the EEG arousal pattern which normally 
results both from stimulation of the reticular formation
-  1 8  -
and certain of its afferent peripheral pathways 
(Konigsmark, Killam & Killam, 1958) • Although the 
activation response produced by amphetamine is not 
blocked by high spinal section (Bradley & Elkes, 1957; 
Schallek & Kuehn, 1959), the drug is unable to activate 
the cortex which is cut off from the influence of the 
reticular formation (Elkes, Elkes & Bradley, 1954).
If, however, portions of the rostral reticular 
formation are spared by the section, then appropriate 
doses of amphetamine still produce the alerting reaction. 
This and other experimental evidence (see reviews by 
Toman & Davis, 1949; Leake, 1958; Himwich, 1959;
Birzis, 1960) indicate that the EEG arousal pattern 
produced by amphetamine is primarily due to a direct 
effect on the reticular activating system, possibly 
through an action on adrenergic neurones (Bradley Sc 
Elkes, 1957). The central stimulant drug, 
dimethylaminoethanol, resembles amphetamine in its 
ability to lower the arousal threshold to stimulation 
of the reticular formation, but this action is weak
and inconsistent (Konigsmark et al., 1958; Himv/ich, 1959) 
In the case of dime thylaminoe thanol, an action on
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adrenergic neurones may not be responsible for the 
effect, since this drug may be a precursor of 
acetylcholine (Murphree, Jenney & Pfeiffer, 1959).
It may, however, still exert a direct action on the 
reticular activating system, since both acetylcholine 
and adrenaline have been shown to lower the threshold 
of the reticular formation to stimulation ( French, 1960 
and references cited).
Methylphenidate resembles amphetamine in its 
ability to alter the EEG to an arousal type pattern 
but this seems to be produced by a different mechanism. 
Unlike amphetamine, the activation produced by 
methylphenidate is not abolished by lesions of the 
midbrain reticular formation (Jouvet & Courjon, 1959). 
This activation is, however, blocked by lesions of the 
diffuse thalamic nuclei (Jouvet & Courjon, 1959).
In the case of me thylphenidate, the arousal pattern may 
be due predominantly to excitation of rostrally-located 
activating neurones but may also be produced by 
inhibition of the recruiting response (Birzis, 1960).
Caffeine seems to produce arousal by yet 
another mechanism. The ability of caffeine to produce
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a low-voltage activation pattern in the EEG is 
not abolished either by the isolation of the cortex 
from the reticular formation or by lesions of the 
diencephalic grey matter (Jouvet & Benoit, Marsallon 
& Courjon, 1957). Caffeine apparently inhibits the 
recruiting response by a direct action on the diffuse 
thalamocortical circuit (Krupp, Monnier & Stille, 1959). 
The possibility that caffeine sensitizes the cortex, 
by producing a relative hypoxia as a result of an 
increased cerebral metabolism in conjunction with a 
reduced blood flow, cannot, however, be discounted 
(Kety, 1959).
Less is known about the effects of the newer 
central nervous system stimulants on the neuro­
physiology of the brain. The following examples 
illustrate some of the difficulties presently associated 
with attempts to correlate the pharmacologibal action 
of these drugs with their effects on electrical 
activity in the brain. The reversible monoamine 
oxidase inhibitor, alpha-me thy 1 tryp tamine, has been 
observed to produce low-voltage fast waves in the EEG 
similar to those produced by amphetamine (Himwich, 1961)
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Although high doses (500 to 900 mg/kg) of the 
irreversible monoamine oxidase inhibitor, iproniazid, 
have been reported to produce this type of EEG pattern, 
the administration of 25 mg/kg daily for 5 days 
produced no apparently persistent change in the EEG 
pattern (Himwich, Costa, Pscheidt & Van Meter, 1959; 
Costa, Pscheidt, Van Meter & Himwich, 1960). Low doses 
of the related monoamine oxidase inhibitors, pheniprazine 
and tranylcypromine, have been reported to produce an 
activation type of pattern in the EEG which is slower 
in onset but of longer duration than that produced by 
amphetamine (Costa ^ ^ 1 . ,  1960). More recently, 
however, the daily administration of iproniazid, 
tranylcypromine, isocarboxazid and nialamide was 
observed to cause a progressive day by day slowing of 
the EEG waves. This pattern resembled that seen in 
sleep, even though the animals were awake at the time 
the EEG was recorded (Funderburk, Finger, Drakontides 
& Schneider, 1962). Furthermore, the arousal threshold 
of the reticular activating system was not apparently 
modified by these four drugs. The antidepressive 
drug, imipramine, produces neurophysiological effects
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similar to those of the phenothiazine tranquillizers. 
Thus it produces slowing of the EEG with high 
amplitude waves and spindles, and depresses the 
reticular activating system (Bradley & Key, 1959).
On this basis there seems to be little foundation for 
its mood-elevating action (Birzis, 1960).
The recent suggestion that the limbic system 
is involved in emotional responses (MacLean, 1958) has 
prompted investigations of the effects of drugs which 
alter the mood on this part of the brain. For 
example, the observations that iproniazid and 
isocarboxazid increase the electrical activity of the 
amygdala, while imipramine depressed the activity of 
the septum, might be reconciled with the psychostimulant 
properties of these compounds "if the amygdala has a 
facilitating influence on behaviour" and "if the septum 
has a restraining influence on behaviour" (Schallek, 
Kuehn & Jew, 1962). These workers also observed, 
however, that the psychodepressants chlordiazepoxide 
and meprobamate also depress the septum. Similarity, 
both pentobarbitone and amphetamine reduce the duration 
of limbic seizures, yet these two drugs are generally
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considered to produce diametrically opposite effects 
on the central nervous system (Kletzkin, 1962). The 
present difficulty in attempting to resolve such 
apparent discrepancies seems to he largely attributable 
to the general lack of knowledge of the precise 
function of the limbic system.
In general it seems that neurophysiological 
data has shown certain broad differences between 
centrally acting drugs such as the depressants and 
stimulants. Research in this field has, however, not 
advanced to the point of being able to associate a 
particular pharmacological effect with a particular 
change in the normal neurophysiological sequence of 
events in the brain. The need for more information 
on similarly acting drugs on neurophysiological 
mechanisms is apparent. By defining more specifically 
the sites of action of the drugs within the brain, 
this type of investigation would appear to offer 
considerable direction to investigations into the 
underlying biochemical means by which the electro- 
physiological changes are produced.
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BIOCHEMICAL ASPECTS
In recent years, many attempts have been made 
to explain the mechanism of action of central stimulant 
drugs in terms of their effects on biochemical processes 
in the brain. For convenience, the theories put 
forward may be divided into those concerned with an 
action of these drugs on central synaptic transmission 
and those concerned with their effects on brain energy 
metabolism. This division does not, however, exclude 
the possibility of a relationship between synaptic 
transmission and energy metabolism.
Central Synaptic Transmission and the Action of Central 
Nervous System Stimulant Drugs.
The existence of chemical mediators, or 
neurohormones, to explain the transmission of impulses 
in the peripheral sympathetic nervous system was first 
clearly suggested by Elliott (1904). The subsequent 
application of this concept to the postganglionic 
parasympathetic synapses(Loewi, 1921), the neuromuscular 
junction (Dale, Feldberg & Vogt, 1936; Brown, Dale & 
Feldberg, 1936; Brown, 1937), and autonomic ganglia
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(Feldberg &  Gaddum, 1934) led to the view that 
transmission at these sites was mediated by 
acetylcholine. In spite of the continuing controversy 
concerning the precise mechanism of action of 
acetylcholine in peripheral neurones and at synapses 
(Nachmansohn, 1959; Katz, 1962; Koelle, 1962), the 
transmission, in higher animals, of peripheral nervous 
impulses from neurone to neurone or from neurone to 
effector cell is now generally believed to be 
accomplished by specific chemical substances, referred 
to as transmitters or neurohormones. The theory of 
chemical transmission at peripheral synapses has, 
furthermore, provided a satisfactory basis for 
explaining the peripheral actions of many drugs,
(e.g. neuromuscular, ganglion and adrenergic blocking 
agents) and their antagonists.
Although the view that transmission across 
synapses in the central nervous system might also be 
mediated by chemical means was tentatively suggested 
in 1937 by Dale, this has not yet been unequivocally
established (see review by Grossland, 1960). The 
nature of the evidence in its favour can be indicated
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briefly. For example, changes in the membrane 
potential of motor neurones in the spinal cord 
accompanying both reflex excitation and inhibition 
appear to arise in the neuronal membrane itself and are 
not passively induced by action currents from the 
stimulated afferent nerves. This suggests that they 
are produced by chemical agents (Brook, Coombs &
Ecoles, 1952). Considerable support for the view 
that the synaptic regions of the central neurones are 
not excited directly by electrical means has accumulated 
(see review by Grundfest, 1957). Electron microscopy 
of the synaptic regions of the central nervous system 
has revealed a space of 120 to 200 & between the pre- 
and post-synaptic membranes (De Robertis, 1959, 1961) 
and the existence of synaptic vescicles in close 
proximity to the presynaptic membrane (Gray & Whittaker, 
1960, 1962). This appearance is consistent with the 
idea that the impulse is transmitted across the synapse 
by chemical means (Eccles & Jaeger, 1958).
The complexity of the central nervous system 
has, however, made the Identification of the 
neurohormones responsible for transmission very difficult.
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A considerable number of substances present In the 
brain have been considered as possible transmitters.
These include acetylcholine (Macintosh, 1941; Feldberg 
8c Vogt, 1948), adrenaline and noradrenaline (Vogt, 1954), 
dopamine (Carlsson, 1959), 5-hydroxytryptamine (Amin, 
Crawford & Caddum, 1960), histamine (Kwiatkowski, 1943), 
gamma-amino butyric acid (Berl & Waelsch, 1958), 
substance P (Von Euler 8c Caddum, 1931; Hellauer &
Umrath, 1948), adenosine triphosphate (ATP) (Holton 8c 
Holton, 1954; Holton, 1959) and an unidentified 
cerebellar factor (Crossland & Mitchell, 1956).
Although a comprehensive review of the literature 
pertaining to the possible role of each of these 
substances in the central nervous system (see reviews 
by Cross land, 1960, Robson 8c Stacey, 1962) is outwith 
the scope of this thesis, a very brief attempt will be 
made to indicate the present situation.
The evidence is probably strongest in the case
of acetylcholine. In the brain, the uneven distribution
of acetylcholine (Macintosh, 1941) is closely paralleled
by the distribution of choline-acetylase necessary for 
its synthesis (Feldberg 8c Vogt, 1948; Hebb & Silver, 195^.
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Choiinesterase, which is necessary for the rapid 
breakdown of acetylcholine, is widely distributed in 
the central nervous system (Burgen & Chipman, 1951). 
Moreover, there is histochemical evidence for the 
presence of acetylcholine near synaptic sites 
(Whittaker, 1959; Gray & Whittaker, 1962). The local 
application of acetylcholine, or an anticholinesterase, 
to the motor cortex causes an increase in the 
activity of the pyramidal tracts (Eccles, Eccles &
Fatt, 1956). The injection of acetylcholine or 
anticholinesterases also causes repetitive firing of 
RenShaw cells, while atropine and dihydro-P-erythroidine 
depress their activity (Curtis & Eccles, 1958).
An Inverse relationship between cerebral electrical 
activity and acetylcholine concentration has been 
observed (Richter & Crossland, 1949; Crossland &
Merrick, 1954). Moreover, acetylcholine can be 
collected from the cortex, if cholinesterase is 
inhibited; the amount is decreased during deep anaesthesia 
and none at all is obtained if the electrical activity 
of the cortex is brought to an end by undercutting it 
(Macintosh & Oborin, 1953). More recently, the
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release of acetylcholine within the cerebrum has 
also been demonstrated (Gaddum, 1961).
Acetylcholine may not, however, be the sole 
transmitter in the central nervous system. In at 
least some regions belonging to the same afferent and 
efferent pathways, there are areas of high and low 
choline-acetylase content. This suggests that there 
are alternating cholinergic and non-cholinergic 
neurones (Feldberg & Vogt, 1948).
There is at present little experimental 
evidence in favour of ATP, the cerebellar factor, 
substance P, or histamine acting as transmitters.
There is some evidence that gamma-aminobutyric acid 
may act as an inhibitory substance, possibly at 
so-called inhibitory synapses (see review by Elliott 
& Jasper, 1959), but its precise function in the 
central nervous system remains unknown (Curtis, Phillis 
& Watkins, 1959). In attempts to find a central 
non-cholinergic transmitter, the catecholamines, 
adrenaline, noradrenaline and dopamine, together with 
5-hydroxytryptamine have received considerable attention. 
The uneven distribution in the brain of these
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substances (Vogt, 1954; Carlsson, 1959; Bogdanskl, 
Welssbach & TJdenfriend, 1957; Kuntzman, Shore,
Bogdanskl & Brodie, 1961), the close association of 
the enzymes required for their synthesis (Bogdanskl 
, 1957; Kuntzman et al., 1961; TJdenfriend & 
Creveling, 1959) and the wide distribution of enzymes 
for their rapid removal (Bogdanskl * 1957;
Axelrod, Albers & Clemente, 1959) is consistent with 
the view that they act as neurohormones. Histochemical 
evidence indicates the presence of 5-hydroxytryptamine 
near central synapses (Gray & IVhittaker, 1960). 
Furthermore, drugs which increase the secretion of the 
adrenal medulla also cause a loss of sympathin from the 
hypothalamus (Vogt, 1954; Holzbauer & Vogt, 1954).
Small doses of adrenaline (Bonvallet, Dell & Hiebel, 1954) 
and noradrenaline (Rothballer, 1956) produce an alerting 
reaction similar to that produced by stimulation of 
the ascending reticular system. Similarly, the 
increase in the brain level of 5-hydroxytryptamine, 
following injection of 5-hydroxytryptophan, is 
associated with signs of central stimulation 
(Bogdanski erb , 1958). These observations suggest
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that noradrenaline and 5-hydroxy tryp tamine may have 
a neurohumoral role in the central nervous system.
The present situation can, therefore, be 
summarized by saying that there is strong, but not 
conclusive evidence, for the existence of a chemical 
transmitter mechanism in the brain, but neither the 
identity of the transmitter or transmitters nor the 
precise nature of the mechanism has been unequivocally 
established. In spite of this, considerable research 
has been directed towards attempts to explain the 
action of central nervous system stimulant drugs on 
the basis of their ability to modify the metabolism 
of hypothetical transmitters, particularly noradrenaline 
and 5-hydroxytryptamine, in the brain.
Thus in 1938 Gaddum and Kwiatkowski suggested 
that the potentiation of the cardiovascular effects of 
adrenaline and sympathetic stimulation produced by 
ephedrine might be explained if ephedrine prevented 
the breakdown of adrenaline. The subsequent 
observations that amphetamine inhibited guinea pig 
liver monoamine oxidase and prevented tyramine-induced 
depression of brain respiration ^  vitro led to the
— 52 —
suggestion that its central stimulant properties were 
due to inhibition of monoamine oxidase (Mann &
Quastel, 1940). In this way, amphetamine was thought 
to prevent the formation of inhibitory aldehydes formed 
during the oxidation of normal amines in the brain.
More recently, however, it has been shown that, in vivo, 
amphetamine neither protects exogenously supplied 
tyramine (Schayer, 1953) or 5-hydroxy tryptamine 
(Sjoerdsma, Gillespie & TJdenfriend, 1959) from 
oxidation nor raises brain levels of 5-hydroxytryptamine 
(Paasonen & Vogt, 1956). Furthermore, amphetamine 
has been observed to cause decreases in the brain levels 
of noradrenaline (McLean & McCartney, 1961; Sanan &
Vogt, 1962; Baird & Lewis, unpublished) and 
5-hydroxytryptamine (Paasonen & Vogt, 1956), The 
decrease in the ratio of noradrenaline to dopamine, 
observed after treatment with amphetamine vivo 
(Baird & Lewis, unpublished) may be related to the 
ability of the drug to inhibit dopamine-p-oxidase 
in vitro (Goldstein & Contrera, 1961), There is also
a lack of correlation between the central stimulant 
activity of the separate optical antipodes of
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l-pheny le thy lamine and amphetamine and their ability 
to inhibit monoamine oxidase (Grana & Lilia, 1959).
All of these later experiments strongly indicate that 
amphetamine does not owe its central stimulant activity 
to its rather weak ability to inhibit monoamine oxidase. 
The suggestion, however, that amphetamine, because of 
its structural similarity to adrenaline and noradrenaline, 
may mimic the central actions of these amines in the 
central adrenergic or ergotropic system (Brodie &
Shore, 1957) has at present no experimental support.
The observations that a number of the newer 
central nervous system stimulant drugs are potent 
inhibitors of monoamine oxidase have, however, revived 
the idea that these two effects may be related. Indeed, 
it seems to be tacitly assumed by many that these new 
drugs owe their central stimulant properties in some 
way to their ability to inhibit monoamine oxidase 
in vitro and in vivo. On the other hand, many 
experimental results on the effects of the so-called 
monoamine oxidase inhibitors render the unreserved 
acceptance of such a view difficult.
One of the basic obstacles is that the enzyme
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monoamine oxidase is capable of oxidizing a wide 
range of amines 3n vitro. These include tyramine, 
5-hydroxytryptamine, noradrenaline, dopamine, tryptamine, 
adrenaline and other amines (Tabor, Tabor & Rosenthal, 
1954; Weissback, Redfield 8c Udenfriend, 1957; Imaizumi, 
Omori, TJnoki, Sano, Watari, Wamba & Inui, 1959; Prate si 
& Blaschko, 1959). It is not surprising, therefore, 
that inhibitors of monoamine oxidase have been found, 
in vivo, to increase brain levels of 5-hydroxytryptamine 
and noradrenaline (Shore, Mead, Runtzman. Specter & 
Brodie, 1957), and dopamine (Holzer & Hornykiewicz, 1959) 
It thus becomes difficult to associate the central 
stimulant actions of these drugs with a change in the 
level of a particular amine in the brain.
Many attempts have, nevertheless, been made to 
show such an association. For example, the excitation 
produced in the rabbit by iproniazid, pheniprazine and 
1-phenyl-3-hydrazinobutane was claimed to be temporally 
related to the rise in the level of noradrenaline in 
the brain rather than to the rise in the level of 
5-hydroxytryptamine (Spector, Shore & Brodie, I960).
These workers also reported that these drugs did not
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produce signs of central stimulation in the dog or 
in the cat and that in these species only the 
5-hydroxytryptamine content of the brain increased.
On the other hand, iproniazid, isocarboxazid, 
tranylcypromine and nialamide have been reported to 
produce central stimulation in the cat, the intensity 
of which was related to the degree of elevation of 
the level of 5-hydroxytryptamine in the brain 
(Funderburk et al., 1962). It has been claimed that 
iproniazid and tranylcypromine can cause a rise in the 
level of noradrenaline in the brain of the rat without 
there being any signs of central stimulation (Green & 
Sawyer, 1960). Moreover, it has been suggested that 
the central stimulation produced by monoamine oxidase 
inhibitors is more closely related to an elevation of 
brain levels of normetadrenaline than of either 
5-hydroxytryptamine or noradrenaline (Carlsson, 1960). 
Other means of elevating the levels of certain amines 
in the brain have been no more successful in relating 
central stimulation to the level of a particular amine. 
Thus the administration of dihydroxyphenylalanine 
increases the brain dopamine level (Bertler &
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Rosengren, 1959) and the administration of 
5-hydroxytryptophan increases the brain level of 
5-hydroxy tryptamine (Bogdanski ^  , 1958; Costa &
Rinaldi, 1958). After both procedures the animals 
show signs of central excitation. There is, however, 
evidence that the same enzyme is responsible both for 
the conversion of dihydroxyphenylalanine to dopamine 
and 5-hydroxytryptophan to 5-hydroxytryptamine 
(Westermann, Balzer & Knell, 1958; Bertler & Rosengren, 
1959; Kuntzman, Shore, Bogdanski & Brodie, 1961).
Thus the effects of administering the two precursors 
may be non-specific, since either dopamine or 
5-hydroxy tryptamine may be formed in areas where they 
are not normally present (Costa, Cessa, Hirsch,
Kuntzman & Brodie, 1962).
Certain other observations indicate that the 
rise in brain amine levels which follows administration 
of potent monoamine oxidase inhibitors may be partly 
due to mechanisms other than inhibition of the enzyme. 
For instance, 30 mg/kg of nialamide produces complete 
inhibition of monoamine oxidase in the brain of the cat, 
yet higher doses are still able to produce greater
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Increases in the brain levels of noradrenaline and 
5-hydroxytryptamine (Funderburk et al., 1962).
Similar observations in the mouse, using a number of 
monoamine oxidase inhibitors, for example, phenelzine, 
pheniprazine, P-phenyle thyIhydraz ine and harmaline, 
indicate that the increase in the levels of these 
amines in the brain may be produced, at least in part, 
by some other mechanism (Dubnick, Lee son & Phillips, 1962). 
These observations may find some explanation from the 
evidence that monoamine oxidase inhibitors prevent the 
release of brain amines from their binding sites 
(Pletscher, 1956; Giarman & Schanberg, 1958; Axelrod,
1962). With regard to noradrenaline, there is now a 
considerable body of opinion which supports the view 
that 0-méthylation plays an important and perhaps major 
role in its metabolism and inactivation (Axelrod, 1960 
and references cited). Thus inhibition of monoamine 
oxidase might not be the sole mechanism by which certain 
drugs increase the levels of amines in the brain. In fact, 
the antidepressive, imipramine, does not significantly 
inhibit monoamine oxidase (Pulver, Exer & Herrmann, 1960),
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yet in the rat it produces a highly significant 
increase in the brain level of 5-hydroxytryptamine 
(Costa, Carattini & Valzelli, 1960).
In spite of these difficulties, Brodie and 
his associates have vigorously promoted a hypothesis 
to explain the central stimulant properties of 
monoamine oxidase inhibitors, which is based on their 
ability to increase the level of free noradrenaline in 
the brain (Brodie & Shore, 1957; Brodie, Spector &
Shore, 1959; Costa e^a^., 1962). This hypothesis 
proposes that noradrenaline and 5-hydroxytryptamine 
are concerned respectively with the control of the 
functionally opposing ergotropic and trqphotropic 
systems of the brain as postulated by Hess (1954).
The presence of free noradrenaline at its specific 
receptor sites is believed to result in ergotropic 
predominance (increased sympathetic activity, 
exaggerated responses to environmental changes, enhanced 
motor activity). Similarly, free 5-hydroxytryptamine 
is believed to lead to trophotropic predominance 
(increased parasympathetic activity, decreased responses 
to environmental influences, decreased motor activity.
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drowsiness and sleep)• The central excitation 
produced by iproniazid (Brodie 1959) and
pheniprazine (Spector 1960) has been reported
to be temporally related to the rise in brain levels 
of noradrenaline. Furthermore, if animals are given 
the monoamine oxidase inhibitor, H-methyl-N-benzyl- 
2-propanylamine, and noradrenaline is then released 
from bound stores by alphamethyl-m-tyro sine, marked 
central stimulation is observed (Costa €|t_^., 1962).
Thus it is suggested that monoamine oxidase inhibitors 
owe their central stimulant properties to their ability 
to increase the brain level of free noradrenaline, 
which in turn produces ergotropic predominance (Costa 
1962). In view of the non-specific nature 
of the enzyme monoamine oxidase and the ability of 
inhibitors of this enzyme to increase brain levels of 
a number of amines other than noradrenaline, such a 
simplified theory cannot as yet be unreservedly 
accepted. Probably the most apt summary of the 
position at this time has been made by Sanan & Vogt (1962)
who stated that ”it seems impossible, at the present 
state of our knowledge, to decide whether monoamine
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oxidase inhibitors exert their stiraillant effect on 
the brain by raising the noradrenaline of the brain 
or by an action on other amines or by totally different 
biochemical processes”.
In view of the evidence in favour of a 
neurohumoral role for acetylcholine in the central 
nervous system, modification of its central functions 
would seem to provide an obvious basis for explaining 
the central action of drugs. As yet, however, the 
possibility that central nervous stimulant drugs may 
act by altering such a mechanism has received little 
attention. It has been suggested that the stimulant, 
dimethylaminoethanol, acts as an acetylcholine 
precursor (Murphree 1959). On the other hand,
a number of central nervous stimulant drugs show 
anticholinergic properties. For example, diphenhydramine 
possesses sedative properties but the o-methyl derivative, 
orphenadrine, is not a sedative but produces euphoria 
and its anticholinergic action is tv/ice that of 
diphenhydramine (Bijlsma, Harms, Funche, Terstegge &
Hauta, 1955). Imipramine has also been shown to be 
a moderately potent anticholinergic (Domenjoz &
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Theobald, 1959) and the potent anticholinergic, 
benactyzine, has been reported to be useful in the 
treatment of depression when used together with 
meprobamate (Alexander, 1958). Several other potent 
anticholinergic compounds produce powerful psychotomimetic 
and antidepressive effects in man (Pink, 1958, 1960;
Abood, Ostfeld & Biel, 1958, 1959). Recently, in a 
study of the structure-activity relationships among 
a group of acetic acid esters of heterocyclic 
aminoalcohols, it was found that only compounds with 
an anticholinergic potency similar to atropine were 
effective as central nervous system stimulants (Biel, 
Nuhfer, Hoya, Leiser& Abood, 1962). Clinically,
Ditran (a 70:30 mixture of N-ethyl-2-pyrrolidylmethyl 
phenylcyclopentylglycolate and H-ethyl-3-piperidyl 
phenylcyclopentylglycolate), which is twice as potent 
an anticholinergic as atropine, has been reported to 
be an effective antidepressive agent (Abood & Meduna, 
1958), Although it has been suggested that such 
anticholinergic compounds may act by interfering with 
the action of acetylcholine in the trophotropic system, 
thus allowing ergotropic predominance (Biel ^  , 1962),
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experimental support for such a hypothesis is not 
available. Thus, although the action of certain 
central stimulant drugs has been considered to be 
related to their ability to alter the normal actions 
of acetylcholine in the brain, present-day evidence 
does not seem to permit a general association between 
these two effects.
With regard to the possibility that central 
nervous stimulant drugs may act by modifying the 
actions of other substances which have been postulated 
as central neurohormones, very little is known. Thus 
a number of compounds including amphetamine, ephedrine 
and caffeine did not change the brain levels of 
substance P (Paasonen & Vogt, 1956), Iproniazid and 
a number of other monoamine oxidase inhibitors have 
been shown to cause a rise in the brain levels of 
free Factor I (gamma-aminobutyric acid) (Elliott &
Van Gelder, 1960) but the precise relationship of 
these findings to the pharmacological actions of the 
drugs remains obscure.
Considerable efforts have thus been made to 
correlate the central stimulant action of drugs with
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their ability to modify the metabolism of possible 
brain neurohormones, in particular, noradrenaline and 
5-hydroxytryptamine. From the limited examples cited 
it can be seen, however, that no clear-cut relationship 
has been demonstrated. This seems to stem largely 
from the lack of knowledge regarding the precise 
function of the possible neurohormones in the brain.
It is nevertheless difficult to escape the conclusion 
that the advent of new central stimulant drugs has, at 
least in part, been responsible for stimulating interest 
and research into the possible functions of these 
substances in the brain. In parallel to endeavours 
to explain the central stimulant action of drugs on 
the basis of a modification of central synaptic 
transmission, a more limited attempt has been made to 
relate the central action of drugs to a modification of 
brain energy metabolism. The possibility of this 
"totally different biochemical process” (Sannen & Vogt, 
1962) being involved in the central action of drugs is, 
therefore, the subject of the ensuing discussion.
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Brain Energy Metabolism and Drugs Which Affect 
Brain Function.
The energy required for the functioning of
the central nervous system is derived almost entirely
from the oxidation of glucose. A much smaller amount
of energy may be derived from the glycolytic breakdown
of glucose to lactic and pyruvic acids. Useful
energy is obtained from both of these processes by
virtue of the fact that they are coupled to the
formation of adenosinetriphosphate (ATP) from
adenosinediphosphate (ADP) and inorganic phosphate (Pi)
Oxidation ,
ADP + Pi ---------— ------- ^
Glycolysis
The breakdown of the ATP formed in this way provides 
the energy required for the activities of the cell.
ATP --------------   ^ ADP f Pi 4- Energy
The relative proportions of ATP and ADP in the cell 
must, therefore, reflect the relative rates of 
energy-requiring and energy-yielding reactions as shown 
in the following diagram.
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A not increase in energy production or a net decrease 
in energy utilization will be reflected by an 
increased level of ATP and a decreased level of ADP. 
Similarly, a net decrease in energy production or a 
net increase in energy utilization will result in a 
decreased level of ATP and increased level of ADP, 
îïewly synthesised adenosinemonophosphate (AMP) may 
be converted to ADP by reaction with ATP
AIÆP + ATP . I   ' 2 ADP
ATP can also be used to convert creatine to 
phosi)hocreatin0 .
ATP + Creatine ADP f Phosphocreatine
Phosphooreatine seems to act as a readily available 
energy reserve which can be used for the rapid 
formation of ATP by reversal of the above reaction. 
Although a number of other phosphorylated compounds
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are found in the brain, the precise functions of 
many of them are unknown (Heald, 1960).
The theory that drugs which affect thé function 
of the central nervous system may do so by modifying 
the energy metabolism of the brain is not a new one.
In particular, many attempts have been made over the 
past thirty years to show that drugs which depress 
the central nervous system do so by diminishing the 
energy available for its functions (see reviews by:
Butler, 1950; Quastel, 1952, 1955; Brody, 1955;
Mcllwain, 1959, 1962; Heald, 1960; Aldridge, 1962).
In 1932, Quastel and Wheatley observed that a number 
of narcotics including ether, chloral, nitrous oxide 
and several alkyl barbiturates depressed the respiration 
of minced guinea pig brain In vitro. The oxidation 
of glucose, pyruvate and lactate was found to be 
particularly sensitive to these narcotics. Moreover, 
brain taken from mice anaesthetized with chloroform 
did not oxidize glucose as well as brain from normal 
mice. Since the degree of inhibition of brain 
respiration in vitro appeared to parallel the 
narcotic potency of the compounds tested, it was suggested
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that the narcosis produced by these drugs was the 
result of an impaired ability of the cells of the 
brain, or some particular area of the brain, to 
oxidize glucose or lactic acid and so provide the 
energy necessary for their normal function. It was 
subsequently found that the respiration of slices of 
brain cortex in vitro (Jowett & Quastel, 1937;
Jowett, 1938) was depressed by lower concentrations 
of narcotics than those used in the early studies with 
minced brain. Many further studies have shown that 
in vitro brain respiration is depressed by a wide 
variety of central nervous system depressants, 
including certain steroidal anaesthetics (Jordan & 
Elliott, 1947), chloral (Buchel & Mcllwain, 1950), 
chlorpromazine (Pinkelstein, Spencer & Ridgeway, 1954), 
reserpine (Century & Horwitt, 1956), and a number of 
barbiturates (Puhrman & Field, 1943; Mcllwain, 1953).
In many cases, however, the concentrations of these 
substances required to depress brain respiration 
in vitro are greater than the concentrations attained
in the brain in vivo after therapeutic doses. 
Concentrations of chloral (Buchel & Mcllwain, 1950),
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plienobarbltone, butobarbltone and allobarbitone 
(Mcllwain, 1953; Cohen & Heald, 1960) comparable to 
those which depress brain function vivo produce 
little or no depression of brain respiration 3^ vitro. 
Indeed phenobarbitone (Westfall, 1949), allobarbitone 
(Mcllwain, 1953) and ethyl alcohol (Wallgren & Kulonen, 
1960) in low concentrations actually produce a slight 
increase in cerebral respiration in vitro. Moreover, 
brain removed from rats one hour after treatment with 
chlorpromazine respires at a higher rate than brain 
removed from control animals (Century & Horwitt, 1956). 
The relationship between the ability of a compound to 
inhibit respiration of the brain 3^ vitro and to produce 
depression of the central nervous system vivo has 
not, therefore, been clearly established.
An alternative theory is that narcotics act 
not so much by inhibiting respiration itself but 
rather by diminishing in some way the amount of ATP 
which it yields (Quastel, 1952, 1955). Thus chloretone 
and pentobarbitone suppress the acétylation of 
sulphanilamide by extracts of pigeon liver when this 
is coupled to the production of ATP by rat brain
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dispersions (Johnson & Quastel, 1953a,b). Since ATP
reversas this depression and the acétylation mechanism 
itself is not affected by the narcotic, it has been 
concluded that the synthesis and not the utilization 
of ATP is depressed. If narcotics do decrease the 
yield of ATP in this way, they may do so by uncoupling 
oxidative phosphorylation (Brody & Bain, 1951). For 
example, concentrations of barbiturates such as 
thiopentone, pentobarbitone and amylobarbitona comparable 
to those found ^  vivo after an anaesthetic dose 
depress the uptake of inorganic phosphate during the 
oxidation of pyruvate by brain mitochondria vitro 
without affecting the rate of oxidation (Brody & Bain, 
1951, 1954; Bain, 1952), Under similar conditions 
these drugs produce the same effect as the classical 
uncoupling agent, dinitrophenol. Anaesthetic 
concentrations of ether and a steroidal anaesthetic 
(Truitt, Bell & Krantz, 1956) have also been shown to 
depress the ratio of phosphate uptake to oxygen uptake 
in particulate preparations of rat brain. A similar
depression is obtained if cerebral mitochondria are 
pre-incubated with concentrations of chlorpromazine
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considerably lower than those found after the 
administration of a therapeutic dose (Abood, 1955).
Higher doses are required when no pre-incubation is 
carried out (Century & Horwitt, 1956; Berger, 1957). 
Reserpine has also been reported to decrease the ratio 
of phosphate uptake to oxygen uptake (Abood &
Romanchek, 1957). Some well known depressants do not, 
however, produce this effect. Notably, ethanol, 
chlorbutanol, chloral, paraldehyde, urethane, morphine 
and anaesthetic mixtures of nitrous oxide/oxygen and 
xenon/oxygen do not depress the ratio of phosphate 
uptake to oxygen uptake in cerebral mitochondria 
(Levy & Featherstone, 1954; Wolpert, Truitt, Bell & 
Krantz, 1956). Allobarbitone and phenobarbitone 
(Brody & Bain, 1954; Wolpert, Truitt, Bell & Krantz, 1956) 
depress both oxygen and phosphorus uptake to about the 
same extent. Similarly, the ability of a number of 
barbiturates to inhibit the synthesis of glutamine 
in brain slices, a process known to depend on an 
adequate supply of ATP, is directly related to a 
decrease in oxygen uptake (Messer, 1958). Moreover, 
concentrations of chloral, butobarbltone and
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allobarbitone which decrease the levels of phosphocreatine 
in slices of guinea pig cerebral cortex also cause a 
fall in oxygen uptake (Buchel Sc Mcllwain, 1950).
On the other hand, chloral at a concentration similar 
to that found in the brain after a sedative dose 
in vivo had no effect on either respiration or 
phosphorylation of cerebral cortex slices Jn vitro 
(Buchel Sc Mcllwain, 1950). It appears, therefore, 
that an ability to depress the formation of energy-rich 
phosphates is not a property common to all central 
nervous system depressants.
It has been found that electrical stimulation 
of cerebral cortex slices vitro causes an increase 
in their oxygen uptake and lactic acid production 
(Mcllwain, 1953), a decrease in their phosphocreatine 
content and an increase in their inorganic phosphate 
level (Heald, 1954; Coheh &  Heald, 1960). The 
metabolic rate can thus be increased to a level closer 
to that operating ^  vivo and partial inhibitions of 
reactions become more easily detectable by their 
ovérall effect (Heald, 1960). Concentrations of 
chloral, urethane, phenobarbitone, butobarbitone,
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allobarbitone (Mcllwain, 1953; Porda & Mcllwain, 1953) 
and chlorpromazine (Mcllwain & Greengard, 1957) similar 
to those found in vivo after therapeutic doses diminish 
markedly the increase in oxygen uptake and lactic acid 
production produced by electrical stimulation 3n vitro. 
The increased respiration of cerebral slices produced 
by potassium ions is also depressed by agents such as 
barbiturates, chloretone, ethanol and chlorpromazine 
in concentrations similar to those used Jn vivo (Ghosh 
& Quastel, 1954; Geddes & Quastel, 1956). The decrease 
in the phosphocreatine level and the increase in the 
inorganic phosphate content produced by electrical 
stimulation of cerebral slices in vitro is also 
inhibited by phenobarbitone in a therapeutic 
concentration (Cohen & Heald, 1960). Since 
phenobarbitone does not change the rate of increase in 
the phosphocreatine level immediately after stimulation 
ceases, it was concluded that this drug does not affect 
the resynthesis of phosphocreatine. The effects of 
narcotics on stimulated cerebral slices Jn vitro is 
thus consistent with the view that they depress the 
utilization of energy.
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Experiments on oxygen uptake and phosphate 
metabolism _in vivo generally support the idea that 
there is a diminished energy utilization in the brain 
during narcosis. Thus there is a decrease in the 
cerebral oxygen uptake during thiopentone anaesthesia 
in man (Kety, 1948; Wechsler, Dripps & Kety, 1951) and 
in the monkey (Schmidt, Kety & Pennes, 1945).
Barbiturate coma and ethanol intoxication in man are 
also associated with a decreased cerebral oxygen uptake 
(Pazekas & Bessman, 1953). A decrease in both oxygen 
and glucose uptake by the brain in man occurs during 
anaesthesia induced by 21-hydroxypregnane-3,20-dione 
or combinations of barbiturates and pethidine (Gordan, 1956). 
During anaesthesia induced by a wide variety of drugs, 
brain levels of phosphocreatine are generally higher 
and ATP levels remain unchanged or are slightly increased 
in spite of the decreased oxygen consumption (Stone, 1940;
Le Page, 1946; Lin, Cohen & Cohen, 1958; Gerlach, Doring 
& Pleckenstein, 1958). After treatment with 
chlorpromazine, an increase in the brain ATP level has 
been reported (Grenell, Mendelson & McElroy, 1955) 
but more recent studies, in which somewhat better
- 54 -
control values were obtained, have indicated no 
change in the brain level of ADP, ATP or 
phosphocreatine (Minard & Davis, 1962). The specific 
radioactivity of ATP in the brains of mice following 
the intracisternal injection of radioactive phosphate 
is, moreover, greater in animals anaesthetized with 
thiopentone or amylobarbitone than in control animals 
(Bain, 1957). This also suggests that the synthesis 
of ATP is not impaired. On the other hand, subnarcotic 
doses of phenobarbitone (Heim & Estler, 1961) and of 
reserpine (Kirpekar & Lewis, 1959) and related 
depressants (Haul & Lewis, unpublished) decrease the 
brain levels of ATP. In these cases it is possible 
that there is a decreased production of ATP.
In summary, the concentrations of depressants 
required to inhibit brain respiration 3^ vitro are 
generally higher than those found in the brain vivo 
after a therapeutic dose. Some, but not all,narcotics 
appear to uncouple oxidative phosphorylation as judged 
by the in vitro depression of the ratio of phosphate
uptake to oxygen uptake. In concentrations similar 
to those found in vivo, certain depressants inhibit
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the increase in oxygen uptake and the decrease in 
phosphocreatine level produced in slices of cerebral 
cortex by electrical stimulation. Similarly, Jn vivo, 
anaesthesia produced by a number of drugs is accompanied 
by a decrease in the oxygen uptake of the brain, yet 
there is no change or an increase in the brain levels 
of energy-rich phosphates. This is consistent with 
the view that there is a decrease in the utilization 
of energy by the brain during narcosis induced by many 
drugs. The suggestion that narcotics depress energy 
production in a particular area of the brain and that 
this in turn results in a general depression of the 
activity of the rest of the brain (Quastel & Wheatley, 
1932; Quastel, 1952) lacks experimental support.
Further experimentation on the effects of mild sedatives 
on brain energy metabolism are required to substantiate 
the possibility that their action may be associated 
with a depression of energy production in the brain.
Much less is known about the effects of central 
nervous system stimulants on brain energy metabolism. 
Little or no indication is given by ^  vitro studies 
that these drugs may act by modifying energy metabolism
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in the brain. Thus amphetamine produces no effect
on the respiration of brain slices vitro unless
high concentrations are used (Mann & Quastel, 1940;
Lu & Krantz, 1953), While caffeine has been observed
to increase the oxygen consumption of slices of rat
brain cortex, ephedrine and amphetamine produce
inhibition (Levy, 1946). Using a similar preparation,
Weiner (1959) reports that amphetamine, mephenteramine
and iproniazid produce no consistent effects. High
— 2 — 4concentrations (10" to lO" M) of amphetamine, 
methylamphetamine, ephedrine, phenmetrazine and 
iproniazid have been shown to depress the respiration 
of slices of rat brain cortex metabolizing glucose 
(Lewis & Pollock, unpublished). Under similar 
conditions, low concentrations (10“^ M) of the anti­
depressive drugs, imipramine and amitryptyline, markedly 
depress oxygen uptake.
Similarly, central nervous system stimulants 
seem to produce no consistent effects on the respiration 
of the brain vivo. Amphetamine may slightly decrease 
(Abreu, Liddle, Burks, Sutherland, Elliott, Simon & Margolis, 
1949) or cause no change in cerebral metabolism vivo
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(Kety, 1959). Caffeine produces no effect (Shenkin, 
1951) or a slight increase (Kety, 1959) in the oxygen 
uptake of the brain in man and no effect on either 
cerebral circulation or metabolism occurs vivo 
after the administration of methylphenidate 
(Ehrmantraut, Shea, Ticktin & Fazekas, 1957). Thus 
neither in vitro nor in vivo studies of the effects 
of central nervous system stimulants on the respiration 
of the brain indicate that these drugs may act by 
modifying energy metabolism.
On the other hand, certain 3m vivo studies 
suggest that central nervous system stimulants modify 
the phosphate metabolism of the brain. Thus 
Palladin (1952) found that four hours after treatment 
with methyl amphetamine, the ATP content of the rabbit 
brain was doubled (Palladin, Khaikina & Polyakova, 1952). 
On this basis it was suggested that the central 
stimulation produced by me thy lamphet amine was due to 
an increase in the energy available for brain functions. 
The brain level of ATP has also been observed to 
increase when central nervous system stimulation is 
produced in the rat by caffeine (Mison-Crighel,
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Constantin© s eu & Crighel, 1959) and in the mous© hy 
both 3-3-iminodiproprionitril© (Earth & Mandel, 1958) 
and ©ther (Estier & Heim, 1960). The observation 
that the rate of incorporation of radioactive phosphate 
into ATP in the brain is greater after treatment with 
me thylamphetamine indicates that the metabolic exchange 
of ATP is increased after this central nervous system 
stimulant is given (Palladin & Rybina, 1953). 
Observations such as these are probably most interesting 
when they are compared to the effects of physiological 
stimulation" of the brain. In this case, if emotional 
excitement is produced in an experimental animal by 
rotating it in a drum, applying electric shocks or 
simply by teasing it with a straw, the ATP content of 
the brain falls (Le Page, 1946; Sytinsky, 1956;
Shapot, 1957). This is not surprising since under 
such conditions the brain may require a greater amount 
of energy to support its increased activity. The 
increase in the ATP level of the brain observed 
during central stimulation produced by drugs, when 
presumably the brain is again requiring more energy 
for its functions, may therefore be due to some direct
— 59 —
effect of the drug on brain energy metabolism. Hot 
all investigators have, however, found an increase 
in the content of ATP in the brain after treatment 
with central nervous system stimulants* Thus Palladin 
and Rybina (1953) report that one hour after treatment 
with me thylamphe tamine, the brain ATP content is 
decreased* It then rises slowly, reaching a normal 
level within two hours, and is above normal four hours 
after treatment. A decrease in the content of ATP 
in the brain has also been found after treatment with 
pheniprazine (Bemsohn, Possley & Gustod, 1959). At 
the present time it is, therefore, difficult to relate 
the central stimulation produced by drugs to their 
ability to increase the ATP level of the brain.
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STATEldEET OF THE PROBLEM
The preceding survey of the literature 
indicates that two main theories have arisen in an 
attempt to explain the mechanism of action of central 
nervous system stimulants. The theory that these 
drugs modify synaptic transmission in the central 
nervous system is hampered by a lack of knowledge of 
the precise mechanism of central synaptic transmission. 
On the other hand, there is very little experimental 
evidence to support the theory that central nervous 
system stimulants owe their action to an ability to 
increase the energy available for brain functions.
The present investigation was, therefore, undertaken in 
an attempt to find out whether or not a relationship 
does in fact exist between the central stimulant action 
of certain central nervous system stimulant drugs and 
their ability to increase brain ATP levels in the rat. 
In order to try to obtain a more complete picture of 
the effects of such drugs on energy metabolism in the 
brain, the levels of AMP, ALP, inorganic phosphate 
and phosphocreatine were also determined. Since 
anaesthesia may affect the levels of ATP and
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phosphoereatine in the brain, the use of anaesthetic 
agents, in conjunction with the central nervous 
system stimulants being studied, was precluded. The 
effects of a number of amphetamine-like central nervous 
system stimulants, monoamine oxidase inhibitors, 
antidepressives resembling phenothiazine in chemical 
structure, and certain related compounds were studied. 
An attempt was made to find out if the potency of 
the different members of each of these groups of drugs 
as central nervous system stimulants was related to 
their ability to change the levels of adenine 
nucleotides, inorganic phosphate and phosphoereatine 
in the brain. A further attempt was made to determine 
whether the effect of a number of the drugs on the 
phosphate metabolism of the brain was qualitatively 
similar at different times during which behavioural 
signs of central nervous system stimulation could be 
observed.
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M E T H O D S
Notes:
1. The methods of preparation of the 
reagents and the quality of the chemicals 
used are shown in Appendix I.
2. During the latter part of this work 
deionized water (conductivity less than 
1.5 X 10“^ ohms/cm; "Elgastat type B.102" 
deionizer) was used in place of distilled 
or triple distilled water.
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The methods used in the experiments described ' 
in the introduction were developed in the following 
order.
1. Methods for estimating adenine nucleotides, 
inorganic orthophosphate and phosphoereatine.
2. Methods for killing the rats, removal of the 
brains and extracting the acid-soluble 
phosphates.
3. Standard procedures for preparing solutions 
of the drugs to be studied.
Finally, an experimental design was devised to facilitate 
statistical analysis of the results.
ASSAY OF ADENINE NUCLEOTIDES 
The necessity of assaying large numbers of 
tissue extracts precluded the use of the time consuming 
salt precipitation, chromatographic, and electrophoretic 
techniques for the separation and assay of adenine 
nucleotides (Heald, 1960 and references cited therein). 
Attention was, therefore, focussed on enzymic methods.
Two of these appeared applicable to the present study.
The first method makes use of the fact that 
nicotinamide adenine nucleotide (HAD) has an absorption
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maximum at a wavelength of 340 n\i in the reduced 
form but not in the oxidized form. By means of a 
series of enzyme-catalyzed reactions with appropriate 
substrates, the conversion of A M P  to ADP, ADP to ATP, 
or ATP to ADP can be coupled stoichiometrically to the 
conversion of NAD from the reduced to the oxidized 
form. The resulting decrease in optical density at 
340 up. can be used to calculate the amount of A M P ,  ADP 
or ATP originally present (Kratzing & Narayanaswami, 
1953; adapted from Slater, 1953; Boehringer).
The second method is based on the fact that AI»IP, 
ADP and ATP all have an absorption maximum at 265 np,, 
whereas the absorption maximum of inosine monophosphate 
(IMP) is at 240 up. (Kalckar, 1947a,b,c). Conversion
of A M P  to IMP, using deaminase, results in a decrease 
in the optical density at 265 up which is proportional 
to the amount of AMP originally present. Moreover, two 
molecules of ADP can be converted to one molecule of AMP 
and one molecule of ATP by myokinase. In the presence 
of deaminase, the deamination of the AMP so formed 
results in a further fall in optical density which is 
proportional to one-half of the amount of ADP originally
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present. ATP can be converted to AMP by apyrase 
and again, if deaminase is present, the optical density 
decreases in proportion to the amount of ATP originally 
present. Thus the concentrations of AMP, ADP and ATP 
can be determined in one run in the spectrophotometer 
by recording the decrease in optical density after the 
successive addition of deaminase, myokinase, and apyrase 
respectively.
Each of these methods has its advantages and 
disadvantages. The first method can be carried out 
with commercially available reagents (although these are 
expensive) but the actual determination is relatively 
complicated and less sensitive. The second method 
was adopted mainly because of its greater sensitivity 
and because AlilP, ADP and ATP can be determined in a 
single run in the spectrophotometer. A commercial 
preparation of myokinase was used (obtained from 
C.P. Boehringer and Soehne GmbH, Mannheim. Western 
Germany). The deaminase and apyrase were prepared as 
described below.
Figure 1
PREPARATION OF DEAMINASE
(Flow Sheet)
AQUEOUS HOMOGENATE OF RABBIT MUSCLE 
ALLOWED TO STAND 18 HOURS AT 5°C
r
SUPERNATANT
DISCARDED
SUPERNATANT
DISCARDED
SUPERNATANT BROUGHT 
TO 0.5 SATURATION WITH 
RESPECT TO (NH^)2S0^
SUPERNATANT
DISCARDED
PRECIPITATE 
(Contains Deaminase) 
EXTRACTED WITH
1 M CH,C00NH^ (pH 8 )
PRECIPITATE TAKEN UP IN HgO 
AND BROUGHT TO 0.5 SATURATION 
WITH RESPECT TO (NH.)gSO.
PRECIPITATE
DISCARDED
PRECIPITATE TAKEN UP IN HgO 
AND DIALYZED AGAINST HgO
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Preparation of Deaminase (Figure 1).
Rabbit muscle deaminase was partially purified
using a modification of "method B" described by
Kalckar (1947c). A rabbit (3-4 kg) was killed by the
intravenous administration of sodium pentobarbitone
(60 mg/kg) and approximately 75 to 100 g of skeletal
muscle quickly removed to a petri dish embedded in
crushed ice. Using an "M.S.E. micro homogenizer", with
the 100 ml vortex beaker surrounded by crushed ice, 50 g
of chilled muscle was homogenized in two batches
(14,000 r.p.m. for 3 minutes each) with a total of 200 ml
of ice-cold distilled water. The homogenate was then 
o
kept at 4 0 for 18 hours, during which time the lactic 
acid, formed from the muscle glycogen, acidified the 
mixture to pH 6 , thus precipitating the deaminase. The 
precipitate was removed by centrifugation (0^0, 30 minutes, 
2200 X g). The deaminase was extracted from the 
precipitate by washing it twice with 150 ml of ice-cold 
1 M ammonium acetate (pH 8 ). In the course of these 
extractions, the precipitate became gelatinous and 
difficult to centrifuge off using the above conditions 
(i.e. 0°G, 30 minutes, 2200 x g). The procedure was, 
therefore, modified, the precipitate being extracted
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only once with 150 ml of ice-cold ammonium acetate 
and the centrifugation carried out in a Spinco 
centrifuge (0^0, 60 minutes, 78,000 x g). This 
modification markedly improved the yield of enzyme.
The supernatant was then warmed slowly to 20^0 and 
fractionated with ammonium sulphate. In the early 
preparations of deaminase, the fractionation was done 
hy adding the required amounts of powdered ammonium 
sulphate to the supernatant with the aid of mechanical 
stirring. The low activity of the enzyme prepared in 
this way prompted the use of a saturated solution of 
ammonium sulphate to effect the fractionation while 
minimizing the danger of denaturing the enzyme by 
localized high salt concentrations (Figure 2). Thus 
by slowly adding 3/7 of the volume of the supernatant 
of saturated ammonium sulphate solution, the supernatant 
was brought to 0.3 saturation, with respect to ammonium 
sulphate. The precipitate so formed was removed by 
centrifugation (20^0, 30 minutes, 2200 x g) and discarded. 
The solution decanted off was brought to 0.5 saturation, 
with respect to ammonium sulphate, by making it up to 
twice the original volume of supernatant with saturated
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aimnonium sulphate solution. The precipitate so 
formed, contained the highest deaminase activity.
It was removed as before, taken up in 15 ml of ice-cold 
distilled water and dialyzed overnight against cold 
distilled water at 4^0.
The activity of the enzyme was then tested 
using the following method. To 1 ml of AMP (5 jimoles) 
was added 16.7 ml of ice-cold 0.3 M perchloric acid 
(PGA) and the volume adjusted to 100 ml with ice-cold 
triple distilled water. To 10 ml of this solution was 
added 10 ml of 0.16 M succinate buffer (pH 6.1), 1 ml 
of 0.1 M GaGlg and 1 ml of 1 M MgGlg. The pH was 
adjusted to 6.1 by titration with 1 N HaOH, using a 
glass electrode assembly, and the volume adjusted to 
25 ml with triple distilled water. A reagent blank 
containing no AMP was similarly prepared. The optical 
density of a 3 ml aliquot of the reagent blank ahd of 
duplicate 3 ml aliquots of the buffered AMP solution 
were read against triple distilled water at a wavelength 
of 265 up. using a spectrophotometer. Following two 
consecutive identical readings of the optical density 
of these three solutions, 0.02 ml of the enzyme was
052
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Figure 2
The Activity of Deaminase Prepared by Different Methods.
The graph shows the change in optical density 
observed when 0.02 ml of deaminase was added to the 
solutions.
-o Curve obtained on addition of deaminase 
prepared using powdered ammonium sulphate 
for the fractionation.
-X  Curve obtained on addition of deaminase 
prepared using a saturated solution of 
ammonium sulphate for the fractionation.
Note the higher rate of reaction when deaminase prepared 
using a saturated solution of ammonium sulphate was used.
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added to each, using an automatic constriction pipette, 
and the solutions briefly stirred. The optical 
density was then determined at 2 minute Intervals until 
no further decrease between two consecutive readings 
for the buffered AMP solutions was found. In order to 
correct for absorption of the enzyme, the rise in optical 
density observed after addition of the enzyme to the 
reagent blank was added to the observed optical density 
of the buffered AMP solutions before the enzyme was 
added to these (Figure 2). The fall in optical density 
due to the conversion of AMP to IMP was, therefore, 
calculated by taking the difference between the corrected 
zero time optical density of the buffered AIÆP solution 
and its optical density when this remained constant 
(Figure 2; Figure 4b). Replacement of the AMP by ADP 
or ATP In this procedure showed that there was no 
appreciable fall in optical density after addition of 
deaminase to these two substrates. The deaminase was, 
therefore, considered to be sufficiently specific to 
be used in the combined assay of A1ÆP, ADP,, and ATP. 
Estimations of different concentrations of AMP using 
this method indicated that the same calibration factor
Table 1
The Estimation of Standard Solutions of Adenine Nucleotides,
All concentrations are those of the buffered solution 
in the spectrophotometer cell. The theoretical 
concentrations are based on a weighed amount of each 
adenine nucleotide.
Number of 
Estimations
Theoretical
Concentration
(npLmoles/ml)
Mean Concentration 
Pound Using Factor 
of 7.34.
(iqimoles/ml- S.D.)
ADEN0SINEMON0PHOSPHATE
8 9.68 9.72 + 0.53
8 16.1 16.5 + 1.2
10 32.6 32.7
+
1.7
ADENOSINEDIPHOSPHATE
2 8.0 8.04 + 0.55
4 9.68 9.75
+
0.97
4 16.1 15.6 + 1.5
3 32.6 31.2
4"
0.4
ADENOSINETRIPHO SPHATE
2 6.18 6.19
+
0.29
12 20.0 20.0
+
0.81
4 25,5 25.7
+
2.0
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used by Purchgott and De Oubareff (1958) was 
applicable to the present investigation (Table 1)•
In view of the importance of deaminase as the rate 
limiting factor in the assay of all three adenine 
nucleotides by Kalckar*s (1947a,b,c) method and the 
possibility of errors occurring due to breakdown of 
ADP and ATP during prolonged runs in the spectrophotometer, 
no deaminase preparation was used which did not complete 
the deamination of 5 nmoles of AMP, under the above 
conditions, within 10 minutes. Furthermore, the 
enzyme was sufficiently active to enable it, when 
diluted three-or four-fold, to complete the above 
reaction in 10 to 15 minutes. The lower blank absorption 
of such an enzyme appeared to contribute considerably 
towards lowering the variation between duplicates.
The enzyme was stored in the concentrated form in 1 ml 
aliquots in tightly stoppered vials either in the liquid 
form at 4^0 or in the frozen state at -15^0. Large 
amounts of highly active deaminase were stored at -15°C 
to prevent the development of bacterial growths.
After 2 to 3 months, however, flocculation was observed. 
Nevertheless, an adequately active enzyme solution
Figure 3
PREPARATION OF APYRASE 
(Plow Sheet)
POTATOES HOMOGENIZED WITH M/lOO RON
SUPERNATANT BROUGHT TO 0.6 SATURATION 
WITH RESPECT TO (NH.)gSO.
PRECIPITATE
DISCARDED
SUPERNATANT
DISCARDED
PRECIPITATE TAKEN UP IN HpO 
AND DIALYZED AGAINST H^O
COMBINED
SUPERNATANTS
PRECIPITATE WASHED WITH H^O
SUPERNATANT
BROUGHT TO 0.6 SATURATION 
WITH RESPECT TO (NH.)2S0^
 1
PRECIPITATE
DISCARDED
SUPERNATANT
DISCARDED
PRECIPITATE TAKEN UP IN H„0 
AND DIALYZED AGAINST HgO
I
SUPERNATANT BROUGHT TO 0.5 SATURATION 
WITH RESPECT TO (NH.)gSO.
PRECIPITATE
DISCARDED
SUPERNATANT BROUGHT TO 0.6 SATURATION 
WITH RESPECT TO (NH^)gSO.
 [  '  ----------------------------
PRECIPITATE
DISCARDED
SUPERNATANT
DISCARDED
PRECIPITATE TAKEN UP IN HgO 
AND DIALYZED AGAINST H^O
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could be prepared by extracting the frozen qliquot 
with one-half the volume of 1.2 M ammonium sulphate 
solution usually used to dilute it and removing the 
precipitate by centrifugation (0°C, 10 minutes, 2200 x g)•
Preparation of Apyrase (Figure 5).
Apyrase (potato adenylpyrophosphatase) was 
prepared using a modification of "method 1" described 
by Krishnan (1949). New potatoes were washed, peeled, 
and 500 g cut into pieces and ground for 3 minutes in 
a Waring Blendor with 500 ml of ice-cold M/100 
potassium cyanide solution. The foam was skimmed 
off and the cell debris removed by centrifugation 
(O^C, 30 minutes, 1000 x g). Approximately 550 ml 
of clear, yellow-coloured, supernatant were decanted 
off and finely powdered ammonium sulphate (45 g/lOO ml) 
was slowly added, with the aid of mechanical stirring, 
to bring the solution to 0.6 saturation with respect 
to this salt and thus precipitate the apyrase. 
Centrifugation (0°C, 45 minutes, 1000 x g), rather 
than overnight filtration (Krishnan, 1949), was used 
to remove the precipitated enzyme. The precipitate
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was taken up in 60 ml of ice-cold distilled water 
and dialyzed at 5°C against a slow continuous flow of 
cold distilled water. The dialysis was further 
facilitated hy mechanically rotating the dialysis sac 
slowly in the distilled water. After the passage of 
about 50 litres of distilled water through the apparatus 
over a period of about 4 hours, the fluid surrounding 
the dialysis sac usually gave no precipitate with 
acidic barium chloride solution. To complete the 
dialysis, the sac was placed in 4 litres of cold 
distilled water and allowed to stand overnight at 5°C.
During the dialysis a brown precipitate of 
insoluble apyrase (Krishnan, 1949) formed in the 
dialysis sac. The material from the dialysis sac was, 
therefore, centrifuged, the supernatant removed to the 
refrigerator, and the precipitate washed successively 
with 30 ml and 20 ml of ice-cold distilled water.
All the supernatants were combined and all the 
separations carried out by centrifugation (0^0 , 20 minutes, 
2200 X g). The combined supernatant was warmed to 
20^0 and brought to 0.6 saturation with respect to 
ammonium sulphate as before. The resulting precipitate
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was removed by centrifugation (20^0, 30 minutes,
2200 X g), taken up in 30 ml of ice-cold distilled 
water and dialyzed as before. On this occasion, much 
less distilled water was required to remove the ammonium 
sulphate than after the first 0.6 saturation. The 
small amount of Insoluble apyrase formed during this 
dialysis was removed by centrifugation (0°C, 30 minutes, 
2200 X g). The supernatant was warmed to 20^0 and 
brought to 0.4 saturation by the slow addition of finely 
powdered ammonium sulphate (30.2 g/lOO ml). The 
precipitate was removed by centrifugation (2 0^0 ,
30 minutes, 2200 x g) and the supernatant brought to 
0.6 saturation by the slow addition of finely powdered 
ammonium sulphate (15.1 g/lOO ml). The small white 
precipitate, which contained the purest fraction of 
apyrase, was then removed by centrifugation (20^0 ,
30 minutes, 2200 x g), taken up in 8 to 10 ml of ice-cold 
triple distilled water, and dialyzed against cold 
distilled water overnight at 5°C.
The pale yellow-coloured solution was removed 
from the dialysis sac and its activity estimated by 
substituting ATP for A1.ÎP in the method described for
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testing deaminase. Deaminase was first added to the 
reagent blank and the buffered ATP solutions in the 
spectrophotometer cells and upon the completion of 
any small decrease in optical density, due to the 
presence of small amounts of AMP, 0.02 ml of apyrase 
was added. The optical density was read at 2 minute 
intervals until no further decrease was observed. 
Apyrase prepared by this method was found to be free 
from AMP-phosphatase activity which would result in 
low ATP values (Purchgott & De Gubareff, 1958).
During the first part of this investigation 
the apyrase was stored in 2 ml aliquots in small 
opaque vials at 5°C. In later work, however, a 
larger amount of apyrase was prepared by doubling all 
quantities in the procedure described. In this case, 
bacterial growths developed in the apyrase before each 
batch was completely used. To overcome this, the 
enzyme was stored in the frozen state at -15^0,
Estimation of AMP^ ADP and ATP in Brain Extracts.
This was done in a manner similar to that 
described for the estimation of AMP by replacing the
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(c) Changes in Optical Density at 265 iqi During 
Analysis of Adenosine triphosphate (ATP) in a 
Brain Extract.
+ A  p represents the increase in optical 
density obtained in the reagent blank on addition 
of apyrase. In this example, + A  E^p = 0 .0 2 2.
- AEj^p represents the fall in optical 
density due to the action of apyrase on ATP and 
subsequent action of deaminase on the AMP formed.
In this example - = 0.109. -A (Figure 4b)
must be subtracted from this to correct for the 
ATP formed by the action of myokinase. Thus 
0.109 - 0.015 or 0.0128 |i mo le s/ml of ATP was
7.34 -
originally present in the spectrophotometer ce.^ 1 .
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(a) Changes in Optical Density at 265 irp. During Analysis 
of Adenosinemonophosphate (AMP) in a Brain Extract.
+ A E represents the increase in optical density 
obtained in the reagent blank on addition of deaminase 
and is due to the ultraviolet absorption of the 
enzyme preparation. In this example, + A  E^ = 0,042.
- A represents the fall in optical density 
due to the action of deaminase on AMP. In this 
example, - A  E^ = 0.033 which is equivalent to
0.033 or 0.00449 mo le s/ml of AMP in the solution
7.34
in the spectrophotometer cell.
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10 ml of AMP solution with 10 ml of a PGA extract 
of the brain. The decreases in optical density 
observed after the successive addition of 0.02 ml of 
deaminase., myokinase and apyrase to the buffered brain 
extract in the spectrophotometer cells were used to 
calculate the concentration of AMP, ADP and ATP 
respectively. Following the addition of myokinase, 
there was a slow non-specific fall in optical density 
and the manufacturer’s instructions for extrapolating 
these optical density readings to the zero time of 
addition of this enzyme were strictly adhered to.
If this is not done, falsely high ADP values are 
obtained. An example of the estimation of AMP, ADP, 
and ATP in a brain extract, together with the method 
of calculation, is illustrated in Figure 4a,b,c, and d.
ESTIMTIOh OF IhORGAMIC PHOSPHATE AND PHOSPHOCREATIhE 
The common methods for the estimation of 
inorganic orthophosphate make use of the blue colour 
developed upon the production of reduced phosphomolybdate 
(Piske & Subbar or;, 1925; Allen, 1940). This reaction 
can be used for the specific determination of inorganic
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phosphate in tissue extracts provided that the 
reagents used and the conditions of the reaction are 
such that there is no hydrolysis of phosphate esters 
(Lowry & Lopez, 1946; Peel, Fox & Elsden, 1955;
Bruemmer & O ’Dell, 1956; Purchgott & De Gubareff, 1956), 
Phosphocreatine can be estimated in such extracts by 
making use of the fact that its phosphate group is 
much more easily removed by treatment with acid than 
are the phosphate groups of the other esters normally 
present (Lowry & Lopez, 1946; Purchgott & De Gubareff, 
1956; Heald, 1960 and references cited therein).
For this investigation, a modification of the 
sensitive microprocedure, described by Purchgott and 
De Gubareff (1956), for the combined estimation of 
inorganic phosphate and phosphocreatine in one reaction 
mixture was used. In this method, inorganic phosphate 
is first rapidly determined colorimetrically under 
weakly acid conditions (pH 2.3). Since there is a 
very slow hydrolysis of phosphoereatine during this 
stage of the reaction, copper ions are added to 
accelerate the formation of the phosphomo.lybdate from 
the inorganic phosphate present so that this is
O'30 r
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Flmre 5
Determination of Inorganic Phosphate In the 
Presence of Phosphocreatine.
The amount of Inorganic phosphate (Pi) is 
determined by extrapolating the 2 to 5 minute 
optical density readings to :3ero time. Thus,
Pi of solution of inorganic phosphate
and phosphocreatine =0*115
Pi of solution of phosphocreatine =0.020
Pi of solution of inorganic phosphate =0,093
Since 0.115 - 0,020— 0.093, Inorganic phosphate 
can be determined in the presence of phosphocreatine.
The addition of HgSO^ hydrolyzes the phosphocreatine.
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completed within 2 minutes of starting the reaction* 
Under these conditions any further colour developed 
after this time is due to the hydrolysis of 
phosphocreatine* Thus, by measuring the optical 
density at 1 minute Intervals for 5 minutes and 
extrapolating the 2 to 5 minute readings to the zero 
time of starting the reaction, it is possible to 
determine the colour developed only from the inorganic 
phosphate present (Figure 5). Sulphuric acid is then 
added to the mixture in the colorimeter cell and the 
extra colour formed, which is due to the ensuing rapid 
hydrolysis of phosphocreatine, is measured. Under 
the conditions of the experiment, this is complete in 
30 minutes. The difference in optical density at 
30 minutes and that at zero time can, therefore, be 
used as a measure of the phosphocreatine concentration 
(Figure 6 ). Thus both inorganic phosphate and 
phosphocreatine are determined in one continuous run 
in either a colorimeter or a spectrophotometer*
The larger amounts of tissue available for 
assay, compared to those used by Furchgott and
0 20
C  0 - 1 0
l-X—X-
» 2 3 4 5 6 7 8 9  l O 15 20 25 3 0
F S M
added
H25O4
a d d e d
Tim e in M in u tes
Figure 7
(a) The Effect of Different Amounts of HqSO.^ 
on the Apparent Rate of Hydrolysis 0? 
Phosphocreatine.
e # 0.63 ml 5 N HgSO^added (1)
X------- X 1.25 ml 5 N HgSO/^added (2)
The figures in brackets indicate the amount 
of H2SO4 as a proportion of the amount used 
by Furchgott and De Gubareff (1956). Note 
that with t7/ice the amount there is no apparent 
hydrolysis as judged by the development of 
colour, A mixture of inorganic phosphate and 
phosphocreatine was used.
Table 2
THE IHFLUEITCE OF VARIOUS CONCENTRATIONS OF COPPER 
SULPHATE OH THE RATE OF COLOUR DEVELOPIÆEHT IH THE 
ASSAY OF TUORGAUIG PHOSPHATE
The optical density at the different times after 
addition of the FSM to the inorganic phosphate 
solution are expressed as a percentage of the final 
constant optical density observed.
Time in 
Minutes 
After 
FSM Added
Final Concentration of CuSO^ in 
Colorimeter Cell
..
0.00016
M
0.00032
M
0.00048
M
0.00064
M
0.0008
M
1
i . . _ .... . .
56 71 76 84 91
2 89 96
.
98 99 100
3 99 99 t 100 
t
100 100
4 100 100 100 100 100
5 100 100 100 100 100
- 78 -
De Gubareff (1956), made a macromodification of their 
method feasible. This was desirable since the 
measurement of larger volumes of reagents incurs 
smaller percentage errors. With two exceptions, this 
was done by proportionally increasing the volumes of 
the reagents used. Firstly, in order that the colour 
development due to the presence of inorganic phosphate 
was complete within 2 minutes of starting the reaction, 
it was necessary to use a five-fold greater concentration 
of copper ions (Table 2). Secondly, to obtain the 
same apparent rate of hydrolysis of phosphocreatine as 
Furchgott and De Gubareff (1956), it was necessary to 
lower the amount of sulphuric acid added (Figure 7).
Experimental Procedure for the Estimation of Inorganic 
Phosphate and Phosphocreatine.
Ten ml of standard inorganic phosphate 
solution, standard phosphocreatine solution, a mixture 
of both, or brain extract were transferred to a test 
tube embedded in crushed ice and containing 0.4 ml of 
0.02 M copper sulphate solution. A reagent blank was 
prepared by adding 10 ml of 0.05 M PGA to a similar
4->
I
■e I
u<0II
« ° P
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8
Slope ■ 33 548
6
4
2
O 0  40 3.02
O p tic a l D en s ity
01
Figure 8
Calibration Curve for Inorganic Phosphate
The optical densities were determined 
using a Hilger Spekker Absorptiometer fitted with 
Ilford number 608 filters to select a wavelength 
of approximately 675 npt. Each point on the 
graph represents the mean of 3 determinations 
and a linear regression line was calculated.
Since the line passes through the origin, 
its slope may be used for calculating unknown 
concentrations of inorganic phosphate. The 
concentrations represent the total inorganic 
phosphate in 100 ml of 0.05 M perchloric acid.
Ten ml aliquots were assayed as described in the 
text. Since the brain extract was always made up 
to a volume of 100 ml and 10 ml assayed similarly, 
the total inorganic phosphate in each brain can be 
directly determined from the slope of the line 
(e.g. 33,548 x zero time optical density of brain 
extract = p.moles inorganic phosphate in the whole 
brain),
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test tube. To each of two, 8 ml capacity, 1 cm 
light path cells were added respectively 5 ml of the 
reagent blank and 5 ml of the test solution. One ml 
of ice-cold Fiske and Subbarow mixture (FSM) was 
added rapidly to each cell using a 1 ml "blow out" 
pipette and the contents stirred briefly with a small 
glass rod. The optical density of the test solution, 
with reference to the reagent blank, was determined 
1,2,3,4, and 5 minutes after the addition of the FSM 
to the test solution. A Hilger Spekker Absorptiometer, 
fitted with Ilford number 608 filters to select a 
wavelength of approximately 675 up,, was used for this 
purpose. At 6 minutes, 0.36 ml of 5 N sulphuric acid 
was delivered rapidly under the surface of the test 
solution using a 1 ml tuberculin syringe fitted with 
a fine polythene tube. The solution was again 
stirred and optical density readings taken each minute 
up to 10 minutes and thereafter at 5 minute intervals 
to 30 minutes.
A calibration curve (Figure 8 ) was constructed 
by estimating different concentrations of standard 
inorganic phosphate solutions in triplicate and
to
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plotting a linear regression line. Since the 
reaction is complete in 2 minutes when only inorganic 
phosphate is present (Figure 5), the mean 2 to 5 
minute optical density readings were used for this 
purpose. It was shov/n by Furchgott & De Gubar eff 
(1956) that the colour development during the second 
part of the reaction, after the addition of the 
sulphuric acid, was lower than during the first part 
of the procedure. It was, therefore, necessary to 
multiply the optical density due to hydrolyzed 
phosphocreatine by the factor of 1.06 in order that 
low values for phosphocreatine were not obtained.
The applicability of this correction factor to the 
present work was confirmed by assaying aliquots of the 
same standard phosphocreatine solutions before and 
after their acid hydrolysis (lOO^C, 10 minutes;
Figure 6; Table 3). In brain extracts, the concentration 
of inorganic phosphate was determined by applying the 
optical denisty at zero time, obtained by extrapolation 
of the 2 to 5 minute readings, to the calibration curve. 
The difference between this optical density at zero
- 81 -
time and that at 30 minutes was multiplied hy the 
correction factor of 1.06 and applied to the same 
calibration curve to obtain the phosphocreatine 
concentrât ion.
BRAIN REMOVAL A3ÜD EXTRACTION 
Rats Killed by Decapitation
Preliminary experiments were conducted using 
a group of untreated rats and a group of rats 
immobilized by the intraperitoneal administration of 
mephenesin (200 mg/kg). The animals were killed 
by decapitation, the brain quickly removed, weighed, 
and homogenized with 25 ml of ice-cold 0.15 M PGA 
in an ”M.S.E. micro homogenizer" (14,000 r.p.m.,
1 minute). The homogenizer blades and the vortex 
beaker were washed successively with 10 ml and 5 ml of 
ice-cold distilled water and the cell debris removed 
from the combined washings and PGA extract by 
centrifugation (0°G, 10 minutes, 2200 x g). The 
precipitate was then re-extracted with 9 ml of ice-cold 
0.15 M PGA and centrifuged as before. The supernatants 
were combined, made up to a volume of 100 ml with 
ice-cold distilled water and assayed for adenine
r i E l
Figure 9
Photograph of the Cages in Which the Rats Were 
Placed After Treatment With the Drug or Control 
Solutions.
95g rats are shown.
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nucleotides.
A comparison of the values obtained using 
this method, with the results of other workers 
(Tablé 4), indicated that this method gave comparatively 
low ATP values and high ADP and AMP values. Attention 
was, therefore, directed towards the method of killing 
the rats by immersion in liquid nitrogen. Rapid 
fixation by this means is believed to minimize the 
breakdown of brain high energy phosphates and yield 
more realistic values (Heald, 1960).
Rats Killed by Immersion in Liquid Hitrogen
Male Wistar strain rats weighing between 75 
and 95 g were used because it is difficult to fix 
rapidly the brains of animals over 100 g in weight in 
liquid nitrogen (Heald, 1960). Immediately after 
treatment with the drug or control solution (see page 86) 
each rat was placed in a small cylindrical cage (Figure 9). 
At the end of the experimental time (*|-, 1^, 3, 4, 6, 
or 12 hours), the cage containing the rat was quickly 
immersed in liquid nitrogen and kept there for 3 to 
5 minutes. The frozen rat was then removed from the
Figure 10
Photograph of the Glove Box in Which Rat Brains 
Were Removed Prom the Heads.
Air is withdrawn from the box by the blower 
and circulated through a water trap and two copper 
tubes, surrounded by solid carbon dioxide and 
methanol, back into the box. This maintains the 
temperature inside the box at -5^0 or lower.
Note large ice-bowl which is filled with liquid 
nitrogen and used to keep the head frozen at all 
times and the small covered insulated beaker 
containing liquid nitrogen where the brain is placed 
when the dissection is completed. The chisels, 
hammer, and dissection board are also shown.
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cage and decapitated with a large chisel. The head 
was then replaced in liquid nitrogen.
Removal of the brain was carried out in a 
glove box maintained at or below -5®C (Figure 10).
A large chisel made from a high-speed power hack saw 
blade (cutting edge about 5 cm long) and two small 
chisels made from tool-steel (cutting edges about 
3 and 9 mm) were found to be the most satisfactory 
for this procedure. Using a small tool-steel chisel, 
the bone was first chipped from the posterior aspect 
of the head to expose the posterior portion of the 
cerebellum and medulla oblongata. Using the large 
chisel, the bone was removed from the lateral aspects 
of the brain by making two cuts parallel to the midline 
approximately through the centre of each eye. Any 
small amounts of bone left on the lateral aspects of 
the brain were carefully removed with a small chisel 
and the top of the cranium prized off. The large 
chisel was then placed at right angles to the midline,
just anterior to the cerebral hemispheres, and lightly 
tapped with a small hammer. This usually caused the
Figure 11
Photograph of Apparatus Used for Pulverizing 
the Frozen Brain.
A stainless steel pestle is chilled by placing 
it in a 50 ml stainless steel centrifuge tube 
embedded in solid carbon dioxide (top left). An 
aluminium foil cover is placed over the pestle to 
prevent frost forming on it; this is shown partly 
removed on left and completely removed on right.
Two other stainless steel centrifuge tubes are 
placed in aluminium foil casings embedded in the 
solid carbon dioxide to chill and are used for 
pulverizing the brain; in the photograph only one 
centrifuge cup is in place. For the pulverization, 
about 25 ml of liquid nitrogen is placed in one of 
the centrifuge tubes. The brain is then placed in 
this and the pestle put gently on top of it. As 
soon as the liquid nitrogen has boiled off, the 
rubber washer around the shaft of the pestle is 
pressed firmly down on top of the centrifuge tube 
and the shaft struck several sharp blows with a hammer. 
The small stainless steel spatula is used to scrape any 
adhering pieces of brain off the pestle back into the 
tube and to scrape the bottom of the tube to make sure 
that the powdered brain is not caked to the bottom 
of it.
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whole brain, with the exception of the olfactory 
lobes, to come loose from the remainder of the skull.
The brain was carefully examined and any small pieces 
of adhering bone removed. It was then transferred 
to an insulated beaker containing clean liquid 
nitrogen. During the removal of the bone from the 
cerebellum, the parafloculi were lost. Throughout 
the dissection the brain was frequently replaced in 
liquid nitrogen and the chisels and forceps used to 
hold it also chilled in this coolant. Finally, the 
brain was transferred from the beaker of liquid nitrogen 
to a torsion balance, the pan of which was chilled in 
liquid nitrogen, weighed, and quickly placed in a 
Dewar flask of liquid nitrogen where it was stored 
until extracted (up to 24 hours).
Extraction of the Brain
The frozen brain was first pulverized in a 
stainless steel centrifuge tube as described by 
Furchgott and De Gubareff (1956). The apparatus 
shown in Figure 11 was used for this purpose.
A small stainless steel spatula, chilled to the
Figure 12
Photograph of the Apparatus Used for Homogenizing 
the Brain.
The stainless steel centrifuge tube is 
embedded in crushed ice. The pestle and shaft 
are plastic and are chilled to O^C before use.
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temperature of solid carbon dioxide, was used to 
scrape the bottom of the centrifuge tube to ensure 
that the powdered brain was not caked to the tube.
The centrifuge tube was then transferred to a beaker 
of crushed ice and allowed to stand 2 minutes. This 
delay was found necessary to prevent freezing of the 
PGA on its addition to the chilled tube. Then 10 ml 
of ice-cold 0.3 M PGA was quickly added with stirring. 
To ensure rapid penetration of the PGA into small 
adhering pieces of brain, the tissue was immediately 
homogenized for 2 minutes using a loosely fitting 
plastic pestle (2000 r.p.m.; Figure 12). The 
suspension was centrifuged (0°G, 6 minutes, 2200 x g) 
and the supernatant filtered at 5°G through a plaited 
9 cm diameter Whatman number 1 filter paper into a 
100 ml volumetric flask packed in crushed ice. The 
tissue was re-extracted with 6.7 ml of ice-cold 0.3 M 
PGA, stirred for 2 minutes, and centrifuged as before. 
The second extract was filtered and combined with the
first. After each filtration, the filter paper was 
washed with approximately 10 ml of ice-cold triple 
distilled water. The volumetric flask was then made
DBÜGS EMPLOYED 
(o) Other antidepressives and related compoimds.
Structural formula 
and approved name
Enantiomorph
employed Source
o c o  -
IMIPEAMINE
Geigy 
Pharmaceutical 
Co. Ltd.
• HCl
AMITHIPTYLINE
Merck Sharpe 
and Dohme Ltd.
• HCl
ORPHENADRINE
racemate Camden Chemical 
Co. Ltd.
N ( CHj ) 2 
1 ll • HCl 
DIPHENHYDRAMINE
Parke Davis 
and Co.
COOCH,
/   ^ • HCl
C j ' ^ H j ) - 0 - 0 0 - < Q
Cocaine
laevo The British Drug Houses Ltd,
Table 5 
DRUGS EMPLOYED 
(b) Monoamine oxidase inhibitors and related compounds
Structural formula 
and approved name
Enant i omorpL. 
employed
Source
c r OHHNECH(CH,)3^2 Roche Products Ltd.
IPRONIAZID
CGimUH.
Smith and Nephew 
Research Ltd.
ISOKIAZID
• m m ,
H2SO4 William R. Warner 
and Co. Ltd.
PHENELZINE
m m
PHENIPRA.ZINE
HCl racemate Bender Laboratories Ltd.
* H2SO4 racemate
TRANYLCYPROMINE
Smith Kline and 
French 
Laboratories Ltd.
HARltllNE • HCl
L. Light and 
Co. Ltd.
Table 5 
DRUGS EMPLOYED 
(a) Amphetamine-like central nervous system stimulants
Structural formula 
and approved name
Enantiomorph 
employed Source
» H2SO4
dextro
laevo
Smith, Kline &  
French 
Laboratories Ltd,
NH
AMPHETAMINE
• HCl
METHYLAMPHETAMINE
dextro
Burroughs 
Wellcome & 
Co,
NHCH 3
HCl
EPHEDRINE
laevo British Drug 
Houses Ltd,
NH
PHEMETRAZINE
HCl
racemate Pfizer Ltd.
NCH
PHENDI1VÎETRAZINE
^4^604
dextro
laevo
Ayerst, Mckenna 
& Harrison Ltd.
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up to the mark with this solvent to produce a final 
concentration of PCA of approximately 0,05 M, Two 
10 ml aliquots of this extract were immediately taken 
for the assay of adenine nucleotides,and inorganic 
phosphate and phosphocreatine, respectively.
PREPARATION OF SOLUTIONS OF DRUGS USED 
The structural formulae, approved names, salt 
used, optical rotation (if any), and sources of the 
drugs used in this investigation are shown in Table 5, 
Each drug was dissolved in 0,9 per cent sodium chloride 
and the solution sterilized. With the exception of 
the solutions of dextro- and laevo-amphetamine and 
me thylamphe tamine, which were sterilized in an autoclave, 
the drug solutions were sterilized by filtration and 
kept in sterile multi-dose containers. Although 
an attempt was made to make the concentration of all 
drug solutions such that, the administration of 0,2 ml 
per 100 g body weight would give the desired dose, the 
low solubility of harmine prevented this. Thus, the 
20 mg/kg doses of harmine and cocaine were given in 
0,4 ml/lOO g body weight and the 10 and 40 mg/kg doses
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of harmine were given in 1.0 ml/lOOg body weight.
In all cases the drug and control (an equivalent 
volume of sterile 0,9^ solium chloride) solutions were 
administered by intraperitoneal injection using all 
glass tuberculin syringes and stainless steel needles 
previously sterilized by heat.
STATISTICAL DESIGN AND ANALYSIS 
Three main considerations were involved in 
devising a statistical design for these experiments. 
First, since the experiments were carried out vivo. 
there was the possibility of the results being affected 
by variation between different animals. Second, it 
was possible that various degrees of breakdown of the 
highly labile phosphate esters might occur during the 
slightly different times of storage of different 
brains in the liquid nitrogen. Third, differences 
in technique during a series of experiments could, it 
was believed, possibly affect the results obtained.
In an attempt, therefore, to minimize the likelihood 
of these sources of variation biasing the results, 
the order of treatment with the drug and control
— 88 ■»
solutions and all subsequent procedures were randomized.
The following methods were used for the 
randomization. Groups of 2 (series 1 and 9) or 
3 (all other series) rats of equal body weight were 
selected from stock. One rat in each group served as 
a control. Two methods of randomizing the order of 
treatment of the rats in each group were used. In 
series 1 and 2 this was accomplished by using a table 
of random numbers and assigning equal chances for each 
treatment to come first or second (series 1) or first, 
second or third (series 2 ) in each group. In all 
other series, except 9 and 10, three 3 x 3  latin 
squares were used to effect the randomization* In 
series 9 and 10 a double randomization was used. For 
each time interval in series 9, the same type of 
statistical design was used as in series 1. The 
statistical design for each time interval in series 10 
was three, 3 x 3  latin squares. In order that a 
direct comparison could be made between the three time
intervals in these two series, the order in which the 
groups from the different times were done was randomized
— 89 —
using three, 3 x 3  latin squares. In all cases, the 
order of killing the rats, removal of the brain, 
extraction, and assay of the brain phosphated followed 
the order of treatment with the drug or control solutions.
The data thus obtained was evaluated employing 
the analysis of variance appropriate to the statistical 
design used (Snedecor, 1956). Samples of the different 
types of statistical designs used and their analysis, 
and one applied experimental protocol, are shown in 
appendix II.
RESULTS
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RESULTS
Amphetamine-like Central Nervous System Stlmalants
Gross Observations
Although no attempt was made to measure the 
degree to which the drugs used in the present experiments 
stimulated the central nervous system, it was obvious 
from the behaviour of the rats that some produced 
greater stimulation than others. In all the 
experiments the control rats soon settled in the small 
cages and were comparatively inactive. Within 15 to 
30 minutes of being placed in the cage they were 
usually dozing or sleeping. Thereafter they would 
from time to time wake up, turn around in the cage, 
and then settle and go back to sleep. It was thus a 
matter of chance whether they were awake or asleep when 
they were plunged into the liquid nitrogen. In 
contrast, the rats which had received ^-amphetamine 
(0.45, 0.90, or 2.5 mg/kg) or d-methylamphetamine 
(0.45 or 0.90 mg/kg) generally remained awake and alert 
up to the time when they were killed (J, 1-^ , 3 and 
4 hours after treatment). They turned around in their
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cages quite frequently and repeatedly washed themselves*
This increase in motor activity seemed to he most 
marked after 2.5 mg/kg of d-amphetamine. The higher 
doses of dl-phenmetrazine (1.80 mg/kg), d-phendimetrazine 
(3.60 mg/kg ), 3.- amphe t amine (10 mg/kg ) and I ” ® Pke dr ine 
(20 mg/kg) produced effects similar to those of the 
lower doses of _d-amphetamine and _d-methy 1 amphetamine.
The lower doses of 1-amphetamine (0.45 mg/kg),
1-ephedrine (0.90 mg/kg), d-phendimetrazine (1.80 mg/kg) 
and 3.-phendimetrazine (3.60 mg/kg) produced little 
effect on the behaviour of the rats.
Effects on Brain Levels of Adenine Nucleotides.
Inorganic Phosphate and Phosphocreatine.
The levels of adenine nucleotides, inorganic
phosphate and phosphocreatine in the brain 4 hours
after injection of the control solution, d-me thy lamphe tamine,
jd- and 3.-am^ ihe tamine, 3.*®P^ Q<3.rine, dl- phenme traz ine
and d- and 3^-phendimetrazine are^  shown in Table 6.
In the doses employed, none of these drugs caused any
significant change in the level of phosphocreatine or
in the total adenine nucleotide content (AMP + ADP + ATP)
of the brain. Although the inorganic phosphate level
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appeared to be lower after treatment with most of 
these drugs, only the decrease observed after 
1.80 mg/kg of dl-phenmetrazIne was statistically 
significant (series 5). Since this effect was not 
observed with the same dose of dl-phenme traz ine in 
series 7, no importance is attached to this isolated 
observation. Similarly, there was only a significant 
fall in the AMP level after 1.-amphe tamine (10 mg/kg), 
3.-ephedrine (20 mg/kg; series 6) and dl- phenme traz ine 
(1.80 mg/kg; series 7).
With the exception of J.-phendime traz ine, after 
a sufficiently high dose of all of these drugs there 
was a significant increase in the ATP level and a 
significant decrease in the ADP level. These changes 
were reflected by a marked and significant increase in 
the ATP/ADP ratio. The dose of each of these drugs 
required to produce this effect seemed to correspond to 
the dose which produced gross signs of central nervous 
system stimulation in the present experiments and which 
has- been reported by other workers to cause hypermotility 
(Brown & Searle, 1938; Schulte et , 1941; Garberg & 
Sandberg, 1960). Using the ratio of ATP/ADP as an
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index, it is immediately obvious from series 2 that 
the laevo isomer of amphetamine is less potent than 
the dextro isomer. Comparing series 1 and 2, 
d-methylamphetamine appears to be slightly more potent 
than d-amphetamine. Prom series 1 and 4 it can be 
seen that 0.90 mg/kg dl-phenmetrazine produced about the 
same increase in the ATP/ADP ratio as 0.45 mg/kg 
d-methylamphetamine. It is apparent from series 4 and 
5 that 1-ephedrine is less potent than d-methylamphetamine, 
d-amphet amine and ^-phenmetrazine. However, after 
high doses of 1-amphetamine (10 mg/kg) and 1-ephedrine 
(20 mg/kg), which produced signs of stimulation, the 
ATP/ADP ratio was increased. Prom series 7 and 8, it is 
apparent that d-phendimetrazine is less potent than 
dl-phenmetrazine and the laevo isomer of phendimetrazine 
is less potent than the dextro isomer. Thus on the 
basis of an ability to increase the ATP/ADP ratio, 
d-methylamphetamine is the most potent compound of this 
group. The dextro isomer of amphetamine v/ould appear 
to be slightly less potent than dl-phenmetrazine. But 
0.45 mg/kg of d-amphet amine produced a significant 
increase in the ATP level and 0.90 mg/kg dl-phenmetrazine
«
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did not. Considering the effects on the levels of 
ADP and ATP as well as the ratio of ATP/aDP, the data 
indicate that _d-amphe tamine is slightly more potent 
that dl- phenme traz ine. The next most potent compound
in the group is probably d-phendimetrazine, although 
3.60 mg/kg amphe tamine was not tested. Since the 
magnitude of the change in the ADP and ATP levels was 
not as great with 20 mg/kg 3.-ephedrine as with 10 mg/kg 
1- amphe tamine, 3.-ephedrine is probably the least potent 
member of the group, although again, doses of 
phendimetrazine higher than 3.60 mg/kg were not 
tested.
The levels of adenine nucleotides, inorganic 
phosphate and phospho ere at ine -g-, l-g- and 3 hours after 
treatment with 0.90 mg/kg of d-methylamphetamine are 
shown in Table 7 (series 9; see appendix II, page xv' 
for statistical design). There was no difference 
between the levels of inorganic phosphate or AMP in 
the drug-treated and control animals at any of the three 
time intervals. The phosphocreatine level was lower 
in the drug-treated animals after 1^ hours. At each of 
the three time intervals the animals treated with 
d-methylamphetamine had a significantly higher level of
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ATP and a significantly higher ATP/ADP ratio. The 
drug-treated animals also had a lower level of ADP 
but this difference was only significant at the i  hour 
and 1-g- hour time intervals. In both the control and 
drug-treated animals the levels of ATP and ADP, and 
the ATP/ADP ratio did not alter significantly in the 
course of the experiment (i.e. no significance between 
l-g- and 3 hour values).
Using a similar statistical design (see 
appendix II, page xvii), the effects at different 
times after treatment with d-amphetamine (2.5 mg/kg) 
and dl-phenmetrazine were also studied (Table 8; 
series 10). There was no difference between the levels 
of inorganic phosphate, phosphocreatine or in the total 
adenine nucleotide content (AMP + ADP + ATP) in the 
drug-treated and control animals at any of the three 
time intervals. At all three time intervals, however, 
the animals treated with both drugs had a significantly 
higher level of ATP and a significantly higher ATP/ADP 
ratio, and significantly lov/er levels of ADP and Æ P .  
Again, during the course of the experiment the values 
observed for each group of animals (i.e. control,
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d-amphetamine and dl-phenmetrazine) showed no 
significant change with time. It shoûld be noted 
that a fall in the AMP level was also observed 4 hours 
after treatment v/ith 1.80 mg/kg dl -phenmetrazine 
(Table 6; series 6 & 7), and 10 and 20 mg/kg 
respectively of 1-amphetamine and 1-ephedrine (Table 6; 
series 6 & 7. These same doses of 1- and d-amphetamine 
and 1-ephedrine, which in the present experiments caused 
a fall in the AMP level as well as a fall in the ADP 
level and rises in the ATP level and the ATP/ADP ratio, 
were those reported to be the most effective so far as 
their ability to increase the motility of rats was 
concerned (Schulte ejb ., 1941)
The experiments of series 9 (Table 7) and 
10 (Table 8) together with the data in Table 6 show, 
therefore, that the same qualitative effects on ATP and 
ADP levels in the brain occur 1-J-, 3 and 4 hours after 
treatment with d-methylamphetamine, d-amphetamine and 
dl-phenmetrazine. At all of these times the rats 
treated with these drugs show behavioural signs of 
central nervous system stimulation.
Table 9
The Comparative Ability of Iproniazid and 
Isoniazid to Diminish the Normal Sleeping 
Time in the Rat.
Each value is the mean of 6 observations 
(- S.E. of mean). The rats were selected in groups 
of 3 of equal body v/eight (80 - 90 g) and the order 
of treatment was randomized using two 3 x 3  latin 
square designs. Each rat was placed in a small 
cylindrical cage. The time in minutes that each 
rat stayed awake during the period 1 to 3 hours 
after treatment was recorded by an observer who did 
not know what treatment each rat had received.
Control Iproniazid 
(40 mg/kg)
Isoniazid 
(40 mg/kg)
50.5 - 9.9 * 95.0 i 8.9 * 90.8 -  9.2
Significance of differences from control:
* 0.05 > P > 0.01
There was no significant difference between 
Iproniazid and Isoniazid.
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Monoamine Oxidase Inhibitors and Related Compounds 
Gross Observations.
In general, the drugs In this group produced 
less marked effects on the behaviour of the rats than 
did amphetamine. Compared to the control rats, those 
treated with Iproniazid and phenelzine appeared to be 
more alert and seemed to sleep less. Since Isoniazid 
Is not used as an antldepresslve drug and Is not 
normally considered to be one. It was at first 
surprising to note that the rats treated with It 
appeared little. If any, different"from those treated 
with Iproniazid. That Is, rats treated with both 
Iproniazid and Isoniazid stayed awake significantly 
longer during the period 1 to 3 hours after treatment 
than did the controls (Table 9). Isoniazid has been 
reported to produce central nervous system stimulation 
In patients being treated for tuberculosis (Salzer & 
Luve, 1953). The animals treated with phenlprazlne 
and tranylcypromine were not only more alert than the 
controls, especially with higher doses, .but they also 
seemed to turn around In their cages more often.
- 98 -
These observations agree with reports that these two 
drugs produce effects similar to amphetamine but less 
Intense in nature (Horita, 1959; Tedeschi et al., 1959; 
Spector et al., 1960). The gross effects produced by- 
bo th phenlprazlne and tranylcypromine began about
hour after Injecting them and were quite marked 3 and 
6 hours after treatment. Twelve hours after treatment, 
the phenlprazlne-treated rats appeared similar to the 
controls while the tranylcypromine-treated rats seemed 
to be still slightly more alert. In contrast, the 
short acting monoamine oxidase Inhibitor, harmlne, 
produced quite different effects. 171thin about 
5 minutes of an Intraperltoneal Injection, a tremor 
developed. Although with lower doses the tremor 
seemed to be Intermittent, the application of external 
stimuli such as snapping the fingers or simply touching 
the rat caused the tremor to become quite violent again. 
These effects were most marked when 40 rag/kg of harmlne 
was given, and In this case, the tremor continued 
almost continuously for about f of an hour. The effect 
seemed to disappear 1 to 2 hours after treatment.
Harmlne also has been reported to produce a tremor In
— 99 —
the mouse (Zetler, 1957). Cocaine produced signs of 
stimulation similar to amphetamine, hut less marked, 
and the effect seemed largely to disappear about 
2 hours after treatment.
Effects on Brain Levels of Adenine Nucleotides. Inorganic 
Phosphate and Phosphoereatine.
The doses of the long acting monoamine oxidase 
Inhibitors used In the present study (phenelzine, 5 mg/kg; 
Iproniazid, 14, 20 & 40 mg/kg; phenlprazlne, 1 & 2 mg/kg; 
tranylcypromine, 2 3c 8 mg/kg) have been reported to 
produce 50 to 100 per cent Inhibition of monoamine 
oxidase In the rat brain vivo (Horita, 1961; Green & 
Erickson, 1960). A dose of 30 mg/kg of harmlne has 
been reported to produce a 63 and 72 per cent Increase 
respectively In the 5-hydroxy try p tamine and noradrenaline 
level of the rat brain (Pletscher, Besendorf, Bachtold 
& Gey, 1959). Doses above and below this (10, 20 &
40 mg/kg) were used In the present study. For comparative 
purposes, Isoniazid was used In the same doses as the
chemically closely related compound. Iproniazid. The 
doses of cocaine used were determined from preliminary 
experiments In which behavioural signs of stimulation
Im
o
g
i
A
i
3
ÜO
m
!
ü
•d«
%
M
II
l9
55
C•H
&
I
KV
■O
C
+»
■g
I
Vh
O
H
03 
+ 1
<T'
C
 ^g
ilVl ü
:5
rs
III
5|l
<M VO VO uv 8 8 8 rH OV rH CM t- d Ch UV uv 8(VJ KvKV rH CM rH CM d CM KVCM rH rH rH CM rH
Q O O O O O O O O O O O O O O O O O
+1 + 1+ 1 HIHI HI HIHI HI HI HIHl Hl Hl Hl Hl Hl
d VO Q rH VO CM CM UV 8 rH O Ch Ch UV 8M -:R ov Kv OV KV KV uv Ch UV 8 O OV Ch CM
CM ■H- d- KVvO 8 CM d KV KV KV
+H++ H-H- HHHH H- +- *
KV O ov VO CM O rH KV KV 8 CM d Ch UV KV 8 CMrH CM rH O rH rH fH rH rH O rH O O rH rH O CM
O O O O O O O O O O O O o O O O O
o + 1 + 1H-l HIHIHI HI HIHI HI HIHl HlHl Hl Hl Hl-<p»n KV t- 8 h- KVVO C^ CM O Chvp O r- 8 d r-+ -< KVVO O KV rH crvCM rH CM Uv d KV CM rH Ov OV
è + KV KV •H d- d d d d d d d d KV KV
S «
OO W- KV KV t~-UV O O 8 r- Ch t— KV C- Ch UVO rH rH O O o O rH rH O o o O rH O O rH
O O O O O O o O O O o o O O O O O
+1 +1+1 HI HIHt HI HIHI HI HIHl Hl Hl Hl Hl Hl
A VO 8 K- OV 4 CM d CM P t- d KV rH rH Ch d ChO rH W- 8 OV d O Ch d O 8 8 UV CM 8 KV*< CM CM CV| CM CM CM CM KV CM CM KV CM CM CM CM CM
» HHHH HHHH 4-4-
UV UV UV KV KV KV UV CM KV UV d d KV UV KV KVo O o O O O o O O O O O O O O O O
o O o O O O O o o O O O O O O O O
+1 +1H-l HIHI HI HIHIHI HI HIHl HlHl Hl HlHl
6} CM KV OV VO UV ov UV 8 8 UV ChUV 8 •H 8 UVA r- UV -K r-8 UV t- d d 8 8 1^ 8 8 Ch 8 r--4 o o O o O o o O O O o O O O o O o
4- H- HHHH HHHH
# uv VO vo KV -d-VO KV KV d d d KV8 KV 8■ o o O O O O o O O O O O O O O O Om*r4 o o o O o o O O O O O O O O O O O
+ 1 +1HI HI HIHI HI HIHI HI HIHl Hl Ht Hl Hl Hl
g y uv uvCM CM VO UV 8 rH 8 8 CM Ov CM d 8 OVW VO VO t- 8 8 1^ 1- h- OV 8 8 8 OV Ch 8 8;O
ifc o O O O O o O O o O O O O O b O c
00
k•
p rH r- UV 8 8 rH t- ov CM d 8 Ch Ch t- o1 # rH rH rH g K H i-HO KVrH CM O rH o rH rHo ArH •âii o O O O o o O O o O O O o O o O O
1 ♦I+ 1HI HIHI HI HIHIHI HI HIHl Hl HlHl Hl Hl
g s 8 KVO OVQ t- CM KV8 KV KV CM KV t- d 8 Chrt K u Ov 8 rH KV3h KV O O OV rH O O O UV8 8 O
KV KV ■H -H d- d d KV d d d d KV KV KV d(3O * «-tH
dk
m rHVO rH CM KV as OV KV rH CM O d 8 KV Ch t-• rH UV OV ■d-KV VO KV8 KV d Ov KV d CM Ch uv
g y-g O O o O O O o O O O O O O O O O o
g + $H-lHI HIHIHI HIHIHI HIHIHl Hl Hl Hl Hl Hl
O UVrH 8 VO VO rH rH O rH uv rH Ch Ch CM 8o o (M o OV uv KV 8 CM rH Ch rH ov rH UV O d d 8
*H K uv w- uv d UV UV d d d UV d d
00
s< O ■KUV O O P O O O O rH CM O O O O g
lî H CM CM d d CM KV
S•H« ad o* « x: tH kd H d «H m N Pv# ■ ri M ▼H d >15 rH d M rH d ■ rH d rH k O rH S S rH •4> O rH O y d O ■H P A rH O d d O dd k d m k d y k C T-t k H k k -H kH* o d H» o d H» O C t; C g y d H» dk d k d k o d k o d • 3 d o d oÊ4 o A o A # o A ■ ' o À k o o O oo M r o M KH o M M p K en o M o P p
S•>
M rH CM KV d uv 8d r* rH rH rH rH rH03
(M
A
k
A
A
k
A
uv
O
o
*
44
I
— 1 0 0  —
were produced by doses of 15 to 40 mg/kg.
The levels of adenine nucleotides. Inorganic 
phosphate and phospho creatine observed 3 hours after 
treatment with these drugs are shown In Table 10.
There was no change in the levels of Inorganic phosphate 
or AMP, and with the exception of cocaine and harmlne 
(series 15), which caused a decrease, there was no 
change In the phospho creatine level. An Increase In 
the total adenine nucleotide content (AMP + ADP + ATP) 
was observed only after 40 mg/kg of Iproniazid.
Although the ATP/ADP ratio was lower after 
20 mg/kg of cocaine (series 15), the ADP and ATP levels 
did not change either after this dose or after 30 mg/kg 
(series 16). Harmlne (20 mg/kg; series 15) produced 
no changes In the ATP/ADP ratio or In the levels of 
ADP and ATP.
However, after all of the other drugs, there was 
a rise In the ATP/ADP ratio but the Increase In the ATP 
level was only significant after phenelzine (5 mg/kg; 
series 11), Iproniazid and isoniazid (20 and 40 mg/kg 
each; series 12 & 13), and phenlprazlne and tranylcypromine 
(1 and 2 mg/kg respectively; series 14). The decrease
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in the ADP level was significant after all of these 
drugs except phenlprazlne and tranylcypromine. In 
these cases where an Increase In the ATP/ADP ratio was 
observed, the drug-treated animals were generally more 
alert than the controls during the time Immediately 
before they were killed. It Is of particular Interest 
to note that Isoniazid and Iproniazid produced similar 
effects on brain adenine nucleotide levels, since both 
compounds. In the higher dose, kept the animals awake 
to the same extent (Table 9). Since Isoniazid Is a 
very weak Inhibitor of monoamine oxidase (Zeller et al., 
1952), and Iproniazid Is relatively much more potent 
In this respect, there does not seem to be a relationship 
between the Inhibition of this enzyme and the ability 
of the drugs to produce signs of central nervous system 
stimulation and to Increase the ratio of ATP/ADP In 
the rat brain.
The effects of harmlne ^  hour after treatment 
when the tremor was distinct are shown In Table 11 
(series 17). Neither 10 mg/kg, which produced mild 
tremor, nor 40 mg/kg, which produced marked tremor, 
caused any significant change In the levels of Inorganic
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phosphate, phospho ere at ine, AIÆP, ADP, ATP or in the 
ATP/ADP ratio. Thus, although harmine is a potent 
monoamine oxidase inhibitor, it neither produces 
characteristic signs of central nervous system stimulation 
nor affects brain phosphate metabolism in the rat.
The effect of cocaine was studied 1^ hour 
after treatment because, at this time, signs of central 
nervous system stimulation were obvious. After both 
15 and 30 mg/kg there were significant increases in 
the ATP/ADP ratio and in the ATP level. Although 
there was a small decrease in the ADP level, neither 
this nor any of the other values changed significantly.
An attempt was also made to find out if an 
increase in the ATP/ADP ratio could be demonstrated at 
different times after treatment with phenlprazlne and 
tranylcypromine when behavioural signs of central 
nervous system stimulation were observed. From Table 12 
it can be seen that there was no change in the levels 
or inorganic phosphate, phosphocreatine, or in the 
total adenine nucleotide content (AMP + ADP + ATP) at 
any of the time intervals. The AMP level was decreased 
3 hours after phenlprazlne. However, -J-, 3 and 6 hours 
after treatment with both drugs, the ATP/a d P ratio was
— 103 —
significantly increased, but after 12 hours it was 
back to the control level. The rise in the ATP level 
and the fall in the ADP level was only significant 
3 and 6 hours after treatment. There seems, therefore, 
to be an approximate relationship between the central 
stimulant action of these two drugs (see page 98) 
and the increase in the ATP/ADP ratio.
Antidepressives Resemblihg Phenothiazine in Chemical 
Structure and other Related Compounds.
Gross Observations;
When compared with the compounds previously 
studied, the behavioural signs of central nervous system 
stimulation produced by the drugs in this group were 
less obvious. Those rats treated with imipramine v/ere 
little different in appearance from the controls in so 
much as they seemed to sleep about the same amount of 
time while they were in the small cages. They were, 
however, considerably more responsive to external 
stimuli. Noises such as that produced by the turning 
on or off of a switch startled them. If they were 
touched with a pencil, they seemed frightened and tried 
to bite it. The rats treated with amitriptyline and
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orphenadrine seemed to sleep less than the controls 
hut did not show signs of hypermotility. On the other 
hand, after treatment with diphenhydramine, which only 
lacks the ortho-methyl group of orphenadrine, the rats 
seemed to sleep more than the controls. This was not 
surprising since one of the common side effects of the 
antihistaminic properties of diphenhydramine is sedation 
(Goodman 8c Gilman, 1955).
Effects on Brain Levels of Adenine Nucleotides. Inorganic 
Phosphate and Phosphocreatine.
The effects of the drugs in this group on the 
brain levels of adenine nucleotides, inorganic phosphate 
and phosphocreatine 3 hours after treatment are shown 
in Table 13. None of these drugs caused any significant 
change in the brain levels of inorganic phosphate, or 
phosphocreatine, or in the total adenine nucleotide 
content (AI.ÎP + ADP + ATB).
VThile the increases in the ATP level and the 
ATP/ADP ratio, and the decreases in the ADP and AMP 
levels were all significant after treatment with 25 mg/kg 
of amitriptyline, this dose of imipramine produced no 
significant effects (series 23), After treatment with
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the larger dose of 50 mg/kg of Imipramine (series 24), 
there was a significant increase in the. ATP level, 
hut neither the ADP level nor the ratio of ATP/ADP 
were changed significantly. When this same dose was 
repeated in series 25, both the rise in the ATP level 
and the ratio of ATP/ADP were significant. That the 
increase in the ratio of ATP/adP was not significant in 
series 24, hut was significant in series 25 is prohahly 
due to the different coefficients of variation in the two 
series (series 24 = 17.7 series 25 = 12.9 % )  * After 
15 mg/kg of orphenadrine, the ATP level and the ratio 
of ATP/adP increased significantly, hut the ADP level 
was not affected (series 24). After 30 mg/kg, however, 
the decrease in the ADP level and increases in the ATP 
level and the ratio of ATP/ADP were all significant 
(series 25), It is of interest to note that the same 
dose (30 mg/kg) of diphenhydramine tended to produce 
the opposite effects; there was a significant increase 
in the ADP level and the ATP level and the ratio of 
ATP/ADP tended to decrease (series 16). The tendency 
of the chemically closely related compounds, orphenadrine
- 106 -
and diphenhydramine, to produce opposite effects on 
the ADP and ATP levels of the brain is of particular 
interest, since these two drugs also seem to produce 
opposite actions on the central nervous system.
V/hile amitriptyline and orphenadrine produced 
similar changes in the adenine nucleotide levels of 
the brain to the central nervous system stimulants of 
the previous groups, imipramine appeared to be somewhat 
different. That is, after the rather high dose of 
50 mg/kg of Imipramine, the ATP level increased but 
the ADP level did not decrease. Since this dose of 
imipramine was close to the dose of 75 mg/kg which vjas 
found to be toxic, the increase in the ATP level may 
be non-specific and unrelated to the antidepressive 
action of the drug. In any case, imipramine does not 
produce typical signs of central nervous system 
stimulation in the rat.
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SUIvHvlARY OP RESULTS
In summary, it was found with these three 
groups of drugs that when signs of central nervous 
system stimulation were observed (alertness, tendency 
to stay awake and in some cases hypermotility), the 
brain ATP level was significantly higher and the ADP 
level significantly lower. This effect was not 
observed when the drugs did not produce signs of central 
nervous system stimulation (e.g. 0.45 mg/kg ^-amphetamine; 
0,90 Sc 1,80 mg/kg n.-ephedrine; 3,60 mg/kg ].-phendimetrazine; 
10, 20 & 30 mg/kg harmine; 20 & 30 mg/kg cocaine 
3 hours after injection; 2 mg/kg pheniprazine & 8 mg/kg 
tranylcypromine 12 hours after injection; 30 mg/kg 
diphenhydramine; imipramine doubtful). There seems, 
therefore, to be some relationship between the central 
nervous system stimulation produced by a number of 
drugs and an increase in the brain ATP level and decrease 
in the brain ADP level in the rat.
DISCUSSION
I s
CI c
.9 :od Q> 
m -p
<D TJ
C•H
00
•H•P
8 t—I 
O
£
CO
Q)
r3
cd
>I
J?
<D -P
CD ^  
o
Tl
00 to 
C 0 •H C -P 04«Î 0 0
o -po
-S H0~> »H
mO 13 ^  C Ph C
4J 0
cd 0 
^  Cp. r-C TO Cd
04 rP
o £ 
g c
cd O  Ciûoc .
O  «Hc o
«Ho
CO
0 o
> e 
0  o 
I-; o
'H -P
s
04
Q  04*< e-i
CD 
+ 1
c•Hci£
0N0
<9
8P
TO
0
r—C
1
<
I 0
5 5P--P TO cd 
O 0 
Xi u
04 Ü
Ü 0 
•H -PS 5LO fi. C TO
5 l
Wc•H
rPfp•Hw
«M
o
13O
X
P
%
0Üss«M
5
Oto Oi 
•  •rv o  
+1
m vf\
o
O
f l
•  •rv o  
+1
r -  to rP
o  o  
+1
rP t> 
CO rP 
•  ♦o  o  
+1
O ^  to VÛ
O
+I
Cvi p f W O
cf\ rv 
44
c0N
O£
S
•8
I
P
a 0 ^  TO C 0 O
S
cv
t."o
»r\
'O
.
o
vO
oJ
-<f
r-4
-d-
c
0N
£
â
po
TO
"c
o
rv
sO
o l
\0
s
o
ir\
CV
5
cv
VPk
Ch
â
po
TO
PCIP
cv
vD
rv
cno
CnI
Vp
CV
gCOo
£
P
c§
pÜ
TO
*CM
m
CV QO VA n5  
• • • •cfN (A i> cn 
fp P
rvc\i Z$S
crvCT\
CNi rvi CNi Pi
p- O O CP 
CP r—I fP CP 
• • • •H P.' CM rP
*>t o  ^rP CM CP 
« •  « •
o  o  o  o
P  -4-NÛ O
o  o  o  o
CP cp ^  00
CPVO to P  
•  *  •  •CM CM CM Pi
1 3  1 3  1 3  1 3
f3 ^
0  TOSf4 U 13
o o
4
rP VP
<s TO TO P  P  p  TO TOo f4TOP
a  TO r û  
 -------
TO TO 
>> r%
4
TO TO 
P  -P TO TO 
U U
V u
VP E>
to O  # ••P o
# •CM CM
Î8CM CM
rP a
VÛ
to
o  o
#o
8
•  •CM O
s
■8
5
TO
SN •V O13 U 0 ^  P  TO P  •H 5 “ 0
PPf TO TO0a
p
5
TO r û
P13
0
13
TO
003
vp
f8 S  « #o  p-
C v^O # «
rP rP
5  ^
O  rP
• •o  o
vO CP 
rP O  • »
rP O
§TO N 0 4S O N 13 TO O 0 tp
£ " 8  X  P  rP P  *H 0P-P 
TO
0 
I
S
Po
TO
"toM
TOÜ
a
p
<3
TO
13
3 8'— 03
vO
#
to
CM
vpO
CM
-■tCM
C3
8
vp
CP
P  UP 
P  O
to CP • •O H
vp r - i
o  o
TO
0N U  
O 0
Ü Ü 
0 0 W 0
IP o
P  CP
OP  0 Ü Q
"to
p .«4 TO
a
TO P
8N
O
£
0
••
a  §o *» (—1 TO rP O p  CO Cm
^ 0CO TO
o>} 0H
n % .o ^
5c8 0 -<+ CQ « CT‘ 
cd rP
>j Cm #.
0 O TOfP TO 
rP to .%
: ■ o
■ ' I S
5  8“
••s 0 •(-<
to ML 4 r ,O  N
^  . g..CM# vO .1 i- l|0  vp 
TO I rP
P j #.
0| 0 O
c > 5
5  SJ-lc3 U£)
CP
i3 P  TO TO
o
•'C'
TO
**s O
plrP O  
0|vO
-TO rP ÜTO *>cH rP -TO TO P  \0  0 TO
CM oy
0I> 13 ip
O  rP S
O•H
-TOP
cd
fe
cp-TO vO Ü
TO S 
rP O 
TO rP TO 0 vD -TO 
O O  Ü rP TO
^  . 5k- TO TO TO 0 P. •H TO 
TO «H •> O 0 CM
P) pe 
..
fP vp |—I
— 108 —
DISCUSSION
The estimation of phosphate esters in the 
brain vivo presents certain difficulties. In 
particular, phosphocreatine and ATP, and to a lesser 
extent ADP, are subject to rapid enzymic hydrolysis 
after death and even in deproteinized solution they are 
quite unstable, especially at extremes of pH. These 
factors must be born in mind in assessing the results 
of any estimations.
The average control levels of inorganic 
phosphate, phosphocreatine (224 observations) and adenine 
nucleotides (263 observations) are shown in Table 14.
A certain amount of variation between the control values 
obtained in the different series of experiments is 
evident from the previous tables of the results (see 
Tables 6, 7, 8, 10, 11, 12 8c 13), With the exception 
of the inorganic phosphate level, this variation was not 
excessive in view of the long period of time over which 
the results were obtained, the possible variation between 
animals and other uncontrollable factors. In the case 
of inorganic phosphate, the large variation appears to 
be due to the very high levels found in certain early
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experiments. These prohahly resulted from contamination 
of the extracts with small chips of hone.
Prom Table 14, it can be seen that the results 
obtained by different workers show considerable 
variation. In general, however, they have obtained 
lower values, particularly of AITP, ADP and ATP. With 
the exception of the values found by Lin and his 
associates (1958; Table 14, reference 3), the total 
adenine nucleotide content (AMP + ADP + ATP) is, 
therefore, considerably lower than that found in the 
present work. Although it is difficult to account for 
this discrepancy, one immediately thinks of the possible 
hydrolysis of ATP to ADP and ADP to AMP. This would 
result in a redistribution of the mono-, di- and tri­
phosphates but would not affect the total adenine 
nucleotide content. Moreover, hydrolysis of ATP would 
probably lead to an increase in the ADP level and a 
decrease in the ATP/ADP ratio. Yet those workers who 
have obtained a markedly higher ATP/ADP ratio (Table 14, 
references 4, 6 & 7) also reported lower ATP levels 
than those found in the present work. The data of 
Lolley and his associates (1961; Table 14, reference 4)
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indicate that the total adenine nucleotide content 
increases with the age of the rat. If such a trend 
continued, one might expect a higher total in the 
present work where rats about six weeks old were used. 
However, Minard and Davis (1962; Table 14, reference 7) 
found a lower total adenine nucleotide content in adult 
rats weighing from 250 to 400 g. The possibility that 
the present high total adenine nucleotide content is 
due to a difference between enzymic and chromatographic 
methods of assay seems unlikely since Weiner (1961;
Table 14, reference 5) found a lower value, despite the 
fact that he also used Kalckar*s (1947b) enzymic method 
of assay. Moreover, the adenine nucleotide levels 
found by Lin and his associates, using a chromatographic 
method, (1958; Table 14, reference 3) agree well with 
the present study. The deamination of AMP to form 
ino sine monophosphate could lead to a decrease in the 
total adenine nucleotide content. This seems unlikely, 
since under conditions where a large amount of hydrolysis 
of ATP seems to have occurred (i.e. decapitation of the 
rat and extraction of the brain without freezing; Table 4, 
opposite page 82), a high AMP level (2.09 p.moles/g) was
- Ill -
found and the total adenine nucleotide content 
(4.16 M-moles/g) was similar to that found using the 
freezing technique.
Although the relatively high total adenine 
nucleotide level found in the present work cannot 
be readily explained by hydrolysis of ATP, the 
comparatively high AMP and ADP levels might be 
explained on this basis. It is, therefore, of 
interest to consider three main places in the 
present method where the hydrolysis of energy-rich 
phosphates seems most likely to occur.
Pirst, there is the possibility of enzymic 
breakdown during the killing of the rat and before 
the brain is fixed. Low ATP and high ADP and AMP 
levels were found in preliminary experiments when 
the rat was killed by decapitation and the brain 
removed and extracted without freezing (Table 4, 
opposite page 82). The technique of decapitation 
was also found to be difficult and these results may 
not only reflect the breakdown of ATP after death but 
may be partly attributable to the excitation of the 
rat before the moment of decapitation. A similar
-  1 1 2  -
decrease in the ATP level has been observed by other 
workers (Table 14, references 5 & 7) when rats were 
decapitated and the brain subsequently frozen. These 
data thus support the view that freezing the brain 
in situ minimizes the breakdown of energy-rich 
phosphates. Such a breakdown is known to occur during 
short periods of ischaemia or anoxia (Poring & Gerlach, 
1957). Moreover, it is reasonable to suppose that the 
violent stimulation of the brain produced by decapitation 
would also produce breakdown of ATP (Weiner, 1962).
It is thus difficult to explain the results obtained 
by Mandel and Earth (1961; Table 14, reference 7) which 
indicate that higher ATP levels are found if the rat 
is decapitated and the head allowed to fall into liquid 
nitrogen than if the whole rat is plunged into liquid 
nitrogen. Although there may well be some breakdown 
of ATP during the few seconds before the brain is 
solidly frozen in situ (Richter & Dawson, 1948), this 
method generally yields higher levels of ATP and 
phosphocreatine and lower levels of ADP and inorganic 
phosphate and appears to be the best available 
(Heald, I960). Purthermore, emotional excitement
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before plunging the rat into liquid nitrogen is known 
to result in a decreased brain ATP level (Le Page, 1946; 
Sytinsky, 1956; see page 58). In view of the 
observation that the ATP level falls and the ALP level 
rises in amphetamine-treated rats which are teased 
with a straw (Shapet, 1957), it was particularly 
important that in the present investigation the rats 
were not disturbed prior to immersion in liquid nitrogen. 
This was avoided by placing the animal in a small cage 
v/hich was plunged directly into the coolant. In any 
case, if emotional excitement did occur during the 
brief period betv/een grasping the handle of the cage 
and plunging it into liquid nitrogen ( 1 to 3 seconds), 
it would probably be more intense in the animals treated 
with drugs which kept them av/ake than in control animals 
which were often asleep at this time. Yet higher levels 
of ATP and lower levels of ALP were found in the animals 
treated with such drugs.
Secondly, some enzymic hydrolysis of labile 
phosphates might occur after the brain is solidly frozen 
and before the enzymes are denatured by the acid 
extraction. This possibility is particularly important
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when one considers that the enzymic dephosphorylation
of ATP and phosphocreatine by brain homogenates is
sufficiently rapid to permit the complete hydrolysis
of the entire amounts found in the brain in a few
seconds (Weiner, 1962). The danger is further
increased by the relatively low temperature coefficient
an
of activity of^adenosinetriphosphatase (Lawson &
Richter, 1950; Weiner, 1961), and the relative 
stability of adenylate kinase in acid (Kalckar, 1947b).
In preliminary experiments, in which the perchloric 
acid was added to the powdered frozen brain and the 
mixture stirred for 20 minutes at O^C, a low ATP level 
and high ALP and AMP levels were obtained (Table 15).
When the acid was added to the frozen powdered brain, 
the tissue tended to freeze into small lumps. 
Homogenization with a loosely fitting plastic pestle, 
to break up these lumps, immediately after addition of 
the acid to the brain resulted in a considerable increase 
in the ATP level and a fall in the ALP and AMP levels. 
Presumably these results indicate that unless the acid 
penetrates the powdered frozen brain quickly and 
completely, enzymic hydrolysis may take place during
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the extraction. Although Weiner (1961) reported that 
homogenization of the tissue with a glass homogenizer 
did not improve the recoveries of adenine nucleotides 
and phosphocreatine, his values, not only for these 
substances but also for AMP and ALP (see Table 14, 
reference 6) are lower than those obtained in the present 
v/ork, despite the fact that he also used Kalckar* s (1947b) 
enzymic method of assay. In other preliminary 
experiments, the brain was extracted and assayed either 
as soon as possible after dissection or after storage 
in liquid nitrogen for 1, 2 or 14 days. Since similar 
levels of adenine nucleotides, inorganic phosphate and 
phosphocreatine were found in all cases, no hydrolysis 
seems to have occurred during storage of the brain under 
these conditions (Table 16). In practice the brain 
was only stored for up to 24 hours.
The third possibility is that non-enzymic 
hydrolysis might occur either in the acid extract or 
in the portion which was buffered to pH 6.1 for the 
assay of adenine nucleotides. To minimize this danger, 
the assays were begun as soon as possible after the 
extraction was completed.
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There is, therefore, little reason to think
that there v;as any significant breakdown of ATP or
phosphocreatine during the present experiments. In
any case, the procedure was the same for both drug-
treated and control rats so that any breakdown of
energy-rich phosphates might be expected to be the
same in both cases and, provided it is not very large,
should not invalidate a comparison. It is of course
conceivable that the presence in the brain of the
drugs being studied might diminish the breakdown of 
an
ATP by^adenosinetriphosphatase during the extraction. 
Such an effect is, however, unlikely since 10“ M 
amphetamine (i.e. 100 to 1000 times the concentration 
attained in vivo) only slightly depresses the activity 
of this enzyme in vitro (Lewis & Pollock, unpublished). 
Finally, the use throughout of random statistical 
designs should minimize any bias which might occur as 
a result of variations between animals or differences 
in experimental technique during the time required to 
complete a series of experiments.
Within the limitations of the methods employed, 
the results of this investigation indicate that the
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brain level of ATP is increased and the brain level 
of ALP decreased in rats when behavioural signs of 
central nervous system stimulation are elicited by 
drugs. These changes are reflected in an increased 
ATP/ALP ratio. This could be due either to a 
decreased utilization or to an increased synthesis 
of ATP. If signs of excitement and fear are produced 
in experimental animals by the application of external 
mechanical or electrical stimulation (see page 58), it 
has been shov/n that the ATP level of the brain falls. 
Since under such conditions there is probably greater 
nervous activity in the brain, the fall in ATP is 
generally believed to reflect increased utilization of 
ATP to support the greater activity. The electrical 
activity of the brain is known to increase after the 
administration of amphetamine-like central nervous 
system stimulants (see pages 17 to 20) and an increased 
utilization of ATP might also be expected in this case. 
Yet an increase in the ATP level was observed. This 
would seem, therefore, to suggest that as well as an 
increased utilization of ATP, there is an even greater 
increase in its synthesis. It is conceivable, however.
-  1 1 8  -
that the depression of a modulating area of the 
central nervous system (e.g. the recruiting response 
of the diffuse thalamocortical system) could lead to 
increased activity of higher centres (e.g. cerebral 
cortex) and behavioural signs of stimulation. In the 
area where activity is depressed, one might expect a 
decreased utilization of energy, while in the area 
where activity is increased a greater utilization of 
energy might occur. Depending upon the balance between 
these two effects, there might be either a decrease or 
an increase in the ATP content of the brain as a whole.
ATP seems to be fairly evenly distributed in the brain 
in so far as gross areas have been examined (cerebral 
cortex, cerebellum, medulla and thalamus-hypothalamus; 
Grenell _et , 1955). Since the cerebral cortex 
represents a large proportion by weight of the whole 
brain, a decreased utilization of ATP in the rest of the 
brain would have to be large to cause a rise in the ATP 
level in the brain as a whole.
The phosphocreatine levels did not change after 
the administration of the central nervous system stimulants 
used in this study, despite the increase in the ATP Jevel.
- 119 -
This may he surprising if it is assumed that an 
equilibrium exists between the ALP-ATP and the 
phosphocreatine-creatine systems and the two systems 
are homogeneously distributed in the brain. It is 
of interest to note that during anaesthesia an increase 
in the phosphocreatine content has been found when there 
was no change in the ATP level. This is directly 
opposite to the present observations. Although 
technical difficulties are involved, such experimental 
findings may indicate that a theoretical equilibrium 
does not exist in a system as complicated and 
heterogeneous as the whole brain.
Although such arguments favour the idea that 
the central nervous system stimulation produced by a 
number of drugs is associated with a net increase in 
the synthesis of ATP in the brain, this has not been 
proved by the results of the present investigation. The 
increase in the ATP/ALP ratio only indicates an 
alteration in the balance between energy utilization 
and production and gives no information as to how the 
change is brought about. The literature on these drugs 
does not throw much light on this question. A tendency
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for low concentrations (10"^ - 10"^ M) of amphetamine 
to increase the content of ATP in rat cerebral cortex 
slices has been reported (Lisovskaya & Livanova, 1959). 
Central nervous system stimulant drugs appear to produce 
little or no effect on brain respiration either vivo 
or when they are added to the tissue to vitro (see 
pages 56 to 57). The _to vitro oxygen consumption of 
brain removed from animals treated with methyl amphetamine 
(Utena, Ezoe, Kato & Hada, 1959), amphetamine and a 
number of monoamine oxidase inhibitors has been observed 
to be higher than that of brain removed from control 
animals (G-reig, Walk & Gibbons, 1959), This effect 
was not produced in liver (Greig et al,, 1959). The 
intensity of anaerobic glycolysis is increased by 
me thy lamphet amine (Palladin, 1952). While both 
increased oxidation and glycolysis could result in an 
increased synthesis of ATP, the oxidative pathway is 
more efficient. Moreover, although glycolysis can 
proceed at a higher rate than oxidation _to vitro 
(Mcllwain, 1959 and references cited), the precise role 
of the anaerobic pathway vivo has not been established. 
In any case, the present lack of evidence that the
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administration of these drugs causes significant changes 
in either oxidation or glycolysis makes it difficult 
to envisage a way in which the rate of synthesis of 
ATP in the brain might be increased.
If it is assumed that central nervous system 
stimulant drugs make more ATP available for brain 
functions, the question arises as to what particular 
processes may be affected to bring about an increase in 
brain activity. Most of the current theories on the 
mode of action of these drugs consider that they modify 
in some way central neurohumoral transmission. It is 
therefore of interest to consider whether an increased 
ATP level in the brain might affect such processes.
There is evidence that ATP may be used for the synthesis 
of both noradrenaline (Kirshner, 1959, 1960), and 
acetylcholine (Mcllwain, 1959 and references cited), 
and a greater amount of ATP might allow the synthesis 
of these compounds to proceed at a higher rate. ATP 
may also be involved in the binding of catecholamines 
in the adrenal medulla (Hillarp, 1960 and references 
cited). If such a mechanism operates in the brain, a 
change in the amount of ATP available might affect the
- 122 —
amount of transmitter released to act on the appropriate 
receptor. The inactivation of catecholamines by the 
enzyme catechol-0-methyltransferase may also require 
ATP (Axelrod et al., 1959) and this could influence 
the concentration of transmitter at the receptor sites.
If any one of these actions does occur, then some direct 
or inverse relationship between the levels of transmitters 
and ATP might be expected. No such relationship was 
revealed in the present experiments. Thus amphetamine 
lowers the noradrenaline content of the brain and 
increases the ATP content. The levels of noradrenaline 
and 5-hydroxytryptamine are increased by many monoamine 
oxidase inhibitors (e.g. iproniazid, phenelzine, 
pheniprazine, tranylcypromine & harmine), but the ATP 
level is not always increased (e.g. harmine). Other 
drugs which apparently have little or no effect on the 
levels of these amines did increase the brain ATP levels 
(e.g. isoniazid, amitriptyline & orphenadrine). Moreover, 
the time course of the increase in brain amine levels 
and ATP produced by pheniprazine and tranylcypromine 
is: différent. The ATP level is high 3 and 6 hours 
after treatment with these drugs but is normal 12 hours
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after treatment. In contrast, the noradrenaline 
level rises to a maximum about 5 hours after treatment 
and then falls very slowly and is still well above 
normal 24 hours after treatment (Grout, Creveling & 
Udenfriend, 1961). Indeed, 2 days after the oral 
administration of 5 mg/kg of tranylcypromine, the 
noradrenaline level of the rat brain is about 50 per 
cent above normal and after 7 days it is still 15 per 
cent above normal (Green & Erickson, I960). Similarly, 
the brain level of 5-hydroxytryptamine rises to a maximum 
6 hours after the administration of pheniprazine, 
remains high for 15 hours, and is still twice the 
normal level after 48 hours (Prockop, Shore & Brodie, 1959) 
Although the brain acetylcholine levels do not apparently 
change after the administration of iproniazid (Giarman 
& Pepeu, 1962), the effects of the other drugs used in 
this investigation on brain acetylcholine levels are 
unknown. No justifiable comparison can be made betv/een 
drug-induced changes in brain ATP and acetylcholine 
levels. The present experiments do not, therefore, 
show any simple relationship between the ability of 
a drug to alter the levels of ATP and the levels 
of central transmitters so far investigated by
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others. Neither do they exclude such a possibility.
A relationship with the functions of acetylcholine or 
other transmitters, the levels of which have not been 
studied after the administration of central nervous 
system stimulant drugs, may exist. Moreover, if an 
increased ATP level facilitated both the binding or 
synthesis and the inactivation of noradrenaline, then, 
depending upon the balance between these two mechanisms, 
the level of the transmitter could increase, decrease 
or not change. Such an effect does, however, seem 
unlikely. For example, the chemically and 
pharmacologically similar drugs, amphetamine and 
pheniprazine, both increase the brain ATP level, yet 
produce opposite effects on the level of noradrenaline. 
Thus in one case the extra ATP would have to be channeled 
towards increased inactivation and in the other case 
increased synthesis or binding of this transmitter.
In peripheral nerves, it seems likely that the 
energy reqi ired for the maintenance of ionic gradients 
across the nerve cell membrane may be supplied by ATP 
(Hodgkin, 1958; Nachmansohn, 1959). In the brain, 
the high turnover rate of ATP and phosphocreatine compared
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with, for example, the rate of acetylcholine synthesis, 
indicates that the largest portion of the energy made 
available by energy-rich phosphates is used for other 
functions, of which the maintenance of ionic balances 
against an electrochemical gradient is probably 
prominent (Dawson & Richter, 1950; Richter, 1952;
Heald, 1960; Mcllwain, 1959, 1962), Certain evidence 
from studies of peripheral nerve transmission make it 
difficult, however, to accept that an increase in the 
available energy would allow a greater rate of nervous 
activity by maintaining ionic gradients in a more 
favourable state. For example, cyanide prevents the 
extrusion of sodium ions from the squid giant axon but 
the fibre is still able to conduct impulses for many 
hours (Hodgkin & Keynes, 1955). One may speculate 
that because of its extreme complexity and the many 
feed-back circuits, the rate of impulse transmission 
in the neurones of the brain is very high compared to 
peripheral neurones. Thus a greater expenditure of 
energy may be required to maintain ionic gradients. 
Under such circumstances it is conceivable that an 
increased availability of energy might facilitate
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nervous activity.
It has so far been assumed that the increased 
ATP level of the brain found after the administration 
of a number of central nervous system stimulant drugs 
is the result of a primary effect of the drugs. This 
may not be true. If one considers a sequence of 
reactions linking the depolarization and repolarization 
of a nerve membrane to the conversion of ADP to ATP 
and of ATP to ADP (see figure 14 of Heald, page 120,
1960), it seems probable that increased nervous 
activity results in a speeding up of this exchange.
If, for example, a central nervous system stimulant drug 
caused increased nervous activity in the brain in some 
other way (e.g. amphetamine may have a direct central 
sympathomimetic action and cocaine may act by releasing 
catecholamines in the brain; van Possum, van der Shoot 
& Hurkmans, 1962), this could result in a greater exchange 
between ATP and ADP. As a result of snchh feed-back 
mechanism, a new dynamic equilibrium might be set up 
between energy utilization and production and so the 
ATP/a d P ratio could change.
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SUIÆIARY Aim OOÏÏOLUSIOUS
The effects of three groups of central nervous 
system stimulants (amphetamine-like, monoamine oxidase 
inhibitors, and antidepressives resembling phenothiazine 
in chemical structure) and some related compounds on 
the levels of adenine nucleotides, inorganic phosphate 
and phosphocreatine in the rat brain have been 
investigated. In all cases where the drugs produced 
signs of central nervous system stimulation (e.g. appropriate 
doses of: d-methylemphetamine, d-amphetamine , 
dl-phenmetrazine, 1-amphetamine, 1-ephedrine, 
d-phendimetrazine, phenelzine, iproniazid, isoniazid, 
tranylcypromine, pheniprazine, cocaine, amitriptyline 
and orphenadrine ) the level of ATP was increased and the 
level of ADP decreased in the brain. Where no obvious 
signs of central nervous system stimulation were observed, 
there was no effect on the brain levels of ADP or ATP.
This was shown with lov/ doses of 1-amphetamine,
1-ephedrine and d-phendimetrazine, 1-phendimetrazine, 
harmine, cocaine (3 hours after injection), and pheniprazine 
and tranylcypromine (12 hours after treatment). 
Diphenhydramine, which produced sedation instead of
-  1 2 8  -
stimulation, tended to cause the opposite effect on the 
brain ADP and ATP levels.
The Increase In the ATP level and the decrease in 
the ADP level may be due either to an increased synthesis 
or to a decreased utilization of ATP. Since there is 
probably an increase in the utilization of ATP to support 
the increased electrical activity of the brain. It is 
believed that the increased level of ATP may be due to a 
net increase in its synthesis. How this might be brought 
about is unknown.
No relationship has been demonstrated between the 
changes in the levels of the hypothetical central transmitters 
reported by other workers to be produced by these drugs and 
the increase in the ATP levels observed in this investigation. 
The possibility that the increased ATP level may play a role 
in the maintenance of ionic gradients in the neurones of the 
central nervous system, and thus facilitate nervous 
transmission, is discussed.
Prom the relatively close relationship found between 
signs of central nervous system stimulation produced in the 
rat by the drugs investigated and the increased ATP level 
and decreased ADP level in the brain, it is concluded that 
this may be an important factor in their action. Whether 
this is a primary or secondary effect of the drugs remains 
a matter for further investigation.
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APgEMDIGIES
APPENDIX I 
Preparation of the Reagents Used.
(In all cases the water used was distilled or deionized)•
Adenosine Monophosphate (AMP), 5 p.moles/ml: 0.0194 g
Sigma AIÆP*Na*H^O dissolved In about 7 ml Ice-cold 
water, pH adjusted to 7 with 1 N NaOH, volume 
made up to 10 ml with Ice-cold water, and 1 ml 
aliquots frozen and stored at -15^0.
Adenosine Diphosphate (ADP), 5 jjimoles/ml: 0.0261 g 
Sigma ADP*2Na*3H20 dissolved In about 7 ml 
Ice-cold water and made up as described for AMP.
Adenosine Triphosphate (ATP), 5 p.moles/ml: 0.0303 g 
Sigma ATP*2Na*3HgO dissolved In about 7 ml of 
Ice-cold water and made up as described for AMP.
Ammonium Acetate, 1 M, pH 8: 19.27 g B.D.H. "Analar^^ 
NH^GOOCEg dissolved In about 225 ml water, 
titrated to pH 8 by adding 1 N NaOH, and volume 
adjusted to 250 ml with water.
Ammonium Sulphate, Saturated Solution: 75.4 g B.D.H. 
"Analar" (NH^)2S0^ added to 100 ml of water, 
warmed to about 25*^ 0 and stirred to dissolve, 
cooled to 20°C and filtered.
- 1 1  -
Ammonium Sulphate, 1.2 M: 15.858 g B.D.H. "Analar 
(NH^)2S0^ dissolved in about 90 ml of water, 
volume adjusted to 100 ml with water and solution 
filtered.
Calcium Chloride, 0.1 M; B.D.H. "Analar" CaCl2 (Dried) 
dried at 150^0 for about 18 hours, 11.099 g taken 
and dissolved in about 900 ml of water, volume 
adjusted to 1000 ml with water, solution divided 
Into 50 ml aliquots in multidose containers, and 
sterilized In an autoclave (10 Lb,/sq.ln. for 
30 minute s).
Copper Sulphate, 0.02 M: 4.9942 g B.D.H. ^^Analar"
Cu S0^*5H20 dissolved In water and volume adjusted 
to 1000 ml with water.
Plske and Subarrow Mixture (PSM): (Both solutions 
stored at 4^0).
(a) Ammonium Molybdate Solution: 2.5 g B.D.H. 
^^Analar" ( 7 ^ 2 4 * ^ ^ 2 dissolved In water 
and volume made up to 100 ml with water.
(b) Reducing Reagent: 2.4 g B.D.H. ”Analar” 
HagSO^'YH^ and 10.9696 g B.D.H. "Reagent Grade”
- I l l  -
HagSgOg dissolved in about 90 ml of water.
0.200 g B.D.H. "Reagent Grade" (0H)S03H
added to this solution and the mixture put on a 
mechanical shaker for 30 minutes. Volume then 
adjusted to 100 ml with water and solution 
filtered.
To make PSM, 2 volumes of (a) and 1 volume of (b) 
were combined on the day of use and kept at 0^0.
Magnesium Chloride, 1 M: 203.33 g B.D.H. "Analar"
MgClg'GHgO dissolved In water, volume adjusted 
to 1000 ml with water, solution divided Into 
50 ml aliquots in multidose containers, and 
sterilized in an autoclave as for Calcium Chloride.
Potassium Cyanide, 0.01 M: 0.6511 g B.D.H. "Analar"
KCN dissolved In water and made up to 1000 ml 
with water.
Perchloric Acid, 0.05 M: 4.1 ml B.D.H. "Analar"
71-73 fo W/lV HCIO^ made up to 1000 ml with water.
Perchloric Acid, 0.15 M: 12.3 ml B.D.H. "Analar"
71-73 fo W/Av HClOg made up to 1000 ml with water.
- IV -
Perchloric Acid, 0.3 M; 24.6 ml B.D.H. "Analar"
71-73 %  W/Ay HClOg made up to 1000 ml with water.
Sodium Chloride, 0.9 % \ Evans Medical Ltd., Sodium 
Chloride Injection B.P. used.
Sodium Hydroxide, IN; B.D.H. Volumetric Solution 
of NaOH, 1 N, used.
Sodium Pentobarbitone ; Nembutal (60 mg/ml) used.
Standard Inorganic Phosphate: 16.3308 g B.D.H. "Analar" 
KHgPO^ dissolved in water and volume adjusted to 
100 ml with water. This solution then diluted 
1 in 100 in 0.05 M PCA to give a 12 p,mole/ml 
solution. Further dilutions of 1 ml, or less, in 
100 ml 0.05 M PCA were made and 10 ml used for the 
assay of Inorganic phosphate as described in the 
"Methods" section of this thesis.
Standard Phosphocreatlne, 5 pmoles/ml: 0.0327 g Sigma 
Phosphocreatine •2Na*4H20 dissolved in ice-cold 
water, volume adjusted to 20 ml, and 1 ml aliquots 
frozen and stored at -15^C. One ml diluted to 
100 ml with 0.05 M PCA and 10 ml used for the assay
- V -
of phosphocreatlne as described In the "Methods" 
section of this thesis.
Succinate Buffer, 0.33 M, pH 6.1 (Kalckar, 1947b):
78.6 g B.D.H. "Analar" succinic acid dissolved 
in about 1000 ml of water, 122 ml 10 N NaOH 
added, volume adjusted to about 1950 ml with water, 
pH adjusted to 6.1 by adding 1 N NaOH, and volume 
then adjusted to 2000 ml with water. Solution 
divided into 100 ml aliquots in multidose 
containers and sterilized in an autoclave as for 
Calcium Chloride. Just before use, 1 volume of 
this solution combined with an equal volume of 
water.
Sulphuric Acid, 5 N: B.D.H. Volumetric Solution of 
H2 SO4 , 5 N, used.
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APPENDIX II
STATISTICAL DESIGNS AND AITALYSIS
SIMPIÆ RAt^DOMIZATIQN OF TITO TREATIjIENTS
Tseries 1)
The rats were selected in pairs of equal body 
weight and whether or not the drug or control animal 
of each pair was injected and the tissue removed and 
assayed first or second was determined using a table 
of random numbers. Equal chances were given for the 
drug or control to come first or second by arbitrarily 
deciding that a number between 0 and 24 in the table 
indicated the control was to come first while a number 
between 25 and 49 indicated that the drug was to come 
first. Thus the following design was obtained;
Group 1 Drug First; Control Second
2 Drug First; Control Second
3 Control First; Drug Second
4 Drug First; Control Second
5 Control First; Drug Second
6 6rug First; Control Second
7 Control First; Drug Second
8 Control First; Drug Second
9 Drug First; Control Second
10 Control First; Drug Second
- vil -
Calculation of Significance Using Analysis of Variance
As a sample the values for the ratio ATP/a d P are given, 
hut the calculations for AI/IP, ADP, ATP and the total 
(AIÆP + ADP + ^TP) are done in a similar way.
Group Control Drug
Treated
Control f 
Dinig Treated
1 1.40 2.51 5.91
2 0.92 1.66 2.58
3 1.42 3.60 5.02
4 2.05 2.38 4.43
5 1.83 3.07 4.90
6 1.66 4.13 5.79
7 1.72 4.71 6.43
8 1.37 2.87 4.24
9 2.27 4.55 6.82
10 3.26 3.58 6.84
Totals 17.90 33.06 50.96
(1) Total Sum of Squares ^
— (1 # 4 0 ( 0 * 9 2 *f 4-(3#26) +(2*51) ----
+(3.58)^ - C*F*. where C.P. - Correction Factor 
= (Grand Total)^
Total number of observations 96)^
Therefore, total sum of squares = 153.8474 - _
20
= 153.8474 - 129.8461 = 24.0013
(2) Drug Versus Control Sum of Squares 
(17.90)^ + (33.06)^ ^
Î0 IS “ - C.P.
= 141.3374 - 129.8461 = 11.4913
(3) Between Groups Sum of Squares
= I£i2ii^+ + --- to 10 terms - C.P.
2 2
= 138.4624 - 129.8461 = 8.6163
(4) Error Sum of Squares
= (1) - (2) - (3) = 24.0013-11.4913-8.6163 = 3.8937
- Vlll -
For Convenience, these calculated values are put 
into a table of the following form in order to 
determine if there are any significant differences.
Source of 
Variation
Degrees
of
Freedom
Sum of 
Squares
Mean
Square
Groups 9 8.6165 0.9574 (a) (a)/(c) 
= 2.21
Drug Versus 
Control
1 11.4913 11.4913 W (t)/(c) 
= 26.56
Error 9 3.8957 0.4326 (o)
Total 19 24.0015
From tables of the distribution of F:
1. Between groups with 9 degrees of freedom for the 
greater mean square (i.e. groups) and 9 degrees 
of freedom for the lesser mean square (i.e. error), 
F at 5 ^ level is 5.81. Since the F value 
found (2.21) is less than this, there is no 
significant difference between groups (e.g. F is 
less than Fq q ^)•
2. Between drug and control with 1 
of freedom respectively for the 
lesser mean squares, F at 0.1 fo 
Since the F value found (26.56) 
this, the difference between the 
values is significant at the 0.1 
(e.g. F is greater than Fq qq^)*
and 9 degrees 
greater and 
level is 22.86. 
is greater than 
drug and control 
fo level
- IX -
SIMPLE RANDOMIZATION OP THREE TREATMENTS
(Series 2)
In series 2, the rats were selected in groups 
of 3 of equal body weight. The order of treatment of 
the animals in each group with the control solution, 
^-amphetamine or 1-amphetamine solutions was determined 
using a table of random numbers and assigning equal 
chances for each treatment to come first, second or 
third. The following statistical design, where 
C = control, 1 = 1-amphe tamine and d = ^-amphetamine, 
was thus obtained.
Group Order
ijarsv üecona Third
1 1 0 d
2 C d 1
3 1 0 d
4 c d 1
5 d C 1
6 d 1 0
7 1 d 0
8 d 1 c
9 0 1 d
10 d C 1
The analysis of variance was similar to that 
used for series 1 except the degrees of freedom were 
changed. As an example, the analysis of variance 
table for the ATP values is given.
Source of 
Variation
Degrees
of
Freedom
Sum of 
Squares
Mean
Square
F
Between
Groups
9 P.3259 (a) 0.0362 a/ 0 = 
1.34
Control versus 
1-amphetamine 
versus
d-amphetamine
2 0.5480 (b) 0.2740 (t)/(o) 
= 10.14
Error 18 0.4864 (c) 0.02704
Total 29 1.3603
-  %  -
From tables of distribution of F:
1. Between groups: Fq q  ^ = 3.55. Since F less
than Fq q ,^ there is no significant difference 
between groups.
2. Between Control and Drug treatments: Fq q^ = 6.01.
Since F is greater than Fq q ^, there is a
difference between the treatments at the 1 fo level
If a difference between two means is significant it 
must be greater than or equal to:
2.101 y  0.02702 (1 /10  + 1 /1 0 ) = 0.1544
Control d-amphet amine 1-amphetamine
Mean Value 2.115 2.395 2.102
Thus the significant difference is between the control 
and d-amphet amine values or between the 1-amphe tamine 
and d-amphetamine values. There is no significance 
between the control and 1-amphetamine values.
The standard error of a single observation
= y  0.02702 = 0.1644 
66.12
Grand mean = 50
Coefficient of Variation =
=  2.2040
0.1644
2.2040
X 100 = 7.46 io
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3 x 3  LAglïï SQUARE DESIGÏÏ 
(series 3 to 8 and 11 to 25 inclusive)
In each of these series, the rats were selected 
in groups of 3 of equal body weight • One rat in each 
group acted as a control while the other two were treated 
with drugs. The order of treatment and all subsequent 
procedures was randomized by using three of the five 
possible 3 x 3  latin squares. As hn example, the 
statistical design for series 4 and the analysis of 
variance of the ATP values are shown. In this series, 
the effects of 0.90 mg/kg 1-ephedrine (E) and 0.90 mg/kg 
dl-phenmetrazine (P) were investigated.
Statistical Design
Column 1 Column 2 Column 3
Group 1 
Group 2 
Group 3
Group 4 
Group 5 
Group 6
Group 7 
Group 8 
Group 9
row 1) 
row 2) 
row 3)
row 4 
row 5 
row 6
row 7 
row 8 
row 9
C
E
P
Column 4
P
E
C
Column 7
E
P
C
P
C
E
Column 5
E
C
P
Column 8
C
E
P
E
P
C
Column 6
C
P
E
Column 9
D
C
E
The data thus obtained is arranged in a table according 
to the treatment and in tables in the same order as it 
was obtained.
Sroup 
or Row
Control E P
1 2.20 2.15 2.47
2 2.15 2.14 2.19
5 2.17 1.96 2.20
4 2.15 1.96 2.42
5 2.21 2.46 1.94
6 1.77 2.03 2.36
7 1.71 1.72 2.13
8 1.69 1.51 2.31
9 2.32 2.01 2.18
Total 18.37 17.94 20.20
tie an 2.04 1.99 2.24
- Xll -
Column 1 Column 2 Column 3 Totals
row 1 2.20 2.47 2.15 6.82
row 2 2.14 2.15 2.19 6.48
row 3 2.20 1.96 2.17 6.33
Totals 6.54 6.58 6.51 19.63
Column 4 Column 5 Column è Totals
row 4 2.42 1.96 2.15 6.53
row 5 2.46 2.21 1.94 6.61
row 6 1.77 2.36 2.03 6.16
Totals 6.65 6.55 6.12 19.30
Column 7 Column 8 Column 9 Totals
row 7 1.72 1.71 2.13 5.56
row 8 2.31 1.51 1.69 5.51
rov/ 9 2.32 2.18 2.01 6.51
Totals 6.35 5.40 5.83 17.58
1. Total Sum of Squares
= (2.20)^+ ----  (2.32)^+ (2.15)^+   (2.01)^+ (2.47)^
+ ----- (2.18)^ - C.P. where O.P. = Total)
27
2
= (56.51) = 118.2733
27
Therefore Total sum of squares = 119.8619 - 118*2733
=  1.5886
2. Treatment Sum of Squares (i.e. control versus E versus P) 
= (18.37)^ + (17.94)^ + (20.20)^  - c.P.
= 118.5934 - 118.2733 = 0.3201
-  X l l - 1  -
3. Blocks Sum of Squares (i.e. Between Latin Squares)
= (19.63)^ + (19.50)^ + (17.58)^  - c.P.
9
= 118.5426 - 118.2733 = 0^26^2
For rows and columns sum of squares the first
term (118.5426) becomes the Correction factor.
4. Rows Sum of Squares
= (6.82)^ + (6.48)^ + (6.33)^ + (6.53)^+ (6.61)^+(6.16)^
3
+ (3.36)^  + (5.51)^ + (6.51)^ _ lie.5426 = 0.2916
5. Columns Sum of Squares
= (6.54)1 +(6.58)^ + (6.51)^ + (6.65)^ +(6.53)^+(6.12)^
+ (6»33)^ + (5.40)^ + (3.83) _ 113.5426 = 0.2030
6. Error Sum of Squares
= (1) - (2 ) - (3 ) - (4 ) - (5)
= 1.5886 - 0.3201 - 0.2693 - 0.2916 - 0.2030 = 0*5043
- XIV -
Analysis of Variance
Source of 
Variation
Degrees
of
Freedom
Sum of 
Squares
Mean
Square
' " - 
F
Blocks 2 0.2693 0.1346 2.12
Rows 6 0.2919 0.0487 <1
Columns 6 0.2030 0.0338 <1
Treatments 2 0.3201 0.1600 3.17
Error 10 0.5043 0.0504
Total 26 1.5886
Significance
1. Blocks: F is less than Fq q .^
Therefore ho significance.
2. Treatments: F is less than F
Therefore no significance.
0.05"
The standard error of a single observation = yO.05043
=  0.2246
Grand mean = = 2.0930
27
Coefficient of Variation =
0.2246
2.0930
= 10.73 io
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STATISTICAL DESICT - DOUBLE RAITDOMIZATIOIT
The rats were selected in pairs and whether the 
control or drug treatment came first or second was 
determined using a table of random numbers and assigning 
equal chances for each treatment to come first or second. 
The effects of the drug at 3 different times after 
injection (-J-, 1-J- & 3 hours) was studied. In order that 
a direct comparison could be made between the effects
at these three times, the order of treatment of the
pairs of rats at each time interval was randomized 
using the 3 x 3 latin square design. Thus the following 
statistical design, where C. = -g- hr. control, 0^ = 1% hr.
control, = 3 hr. control, D. = -& hr. drug. Dp = 1-& hr.
drug, and = 3 hr. drug, was obtained:
"^ 3 °3 O2 ^2
®2 % °3 “ 3
O2 ^3 I>2 O2 ^1
^3 "3 ^2 %
El ^3 °3 ^2 °2
^2 °2 °3 ^3
Cl E2 C2 C3 ^3
°2 ^2 C3 ^3 ^1 Cl
^3 C3 Cl Cg D2
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It is apparent that §,11 of the control values 
make up a 3 % 3 latin square design and accordingly 
they were analyzed in the manner previously described 
(pages xi - xiv) to find out if there was any significant 
difference betv/een the values obtained at the three 
different time intervals. Similarly, all of the drug 
values were analyzed to find out if there was any 
significant difference betv/een the values obtained at 
the three different times. In no case was any 
significant difference found between the three different 
times.
Since the pairs from the three different time 
intervals also form a 3 x 3 latin square design, the 
difference between the drug and control values at each 
time interval was similarly analyzed to find out if 
there was any significant difference between the drug 
and control values. As an example of this, the 
analysis of variance table for the control minus the 
drug values for ADP is shown below.
Variation 
due to
Degrees
Freedom
Sum of 
Squares
Mean
Square F
Blocks 2 0.0020 0.0010 1
Rows 6 0.0514 0.0086 1
Columns 6 0.1012 0.0169 1.44
■g- hr. versus 1 hr. 
versus 3 hr.
2 0.0692 0.0345 2.95
Error 10 0.1174 0.0117
Total 26 0.3412
There are no significant P values.
- zvii-
From the table, the standard error of the 
difference between the control and drug values for 
AD? equals /O’.01174. If a mean difference between the 
control and drug value is to be significantly different 
from zero (on the 5 fo level of significance) it must be 
greater than or equal to
2.228 y ir. 01174 = 0.081
9
(2.228 is the *t* value for error degrees of freedom 
of 10 at the 5 ^ level of significance. The *t * value 
at any other level of significance may be substituted 
to find the appropriate level of significance).
In the present case of AD? values the mean differences 
at the different times were:
Op - - 0.144 (i.e. -g- hour)
Cg - Eg = 0.065 (i.e. 1-g- hour)
C3 - E3 = 0.188 (i.e. 3 hours)
■ hour and 3 hours after treatment, the
treated animals have a significantly lower ADP level
than the control animals (at the 5 ^ level of significance) •
Using the *t* value of 3.169 for the 1 fo level 
of significance, a difference would have to be greater 
than 0.112 to be significant at this level.
Using the *t’ value of 3.169 for the 1 fo level 
of significance, a difference would have to be greater 
than 0.112 to be significant at this level.
Using the *t* value of 4.587 for the 0.1 fo level 
of significance, a difference would have to be greater 
than 0.165 to be significant.
Therefore, the difference was significant
at the 1 fo level (i.e. 0.01 >P >0.001). The difference
Cj - Dj was significant at the 0.1 ^ level (i.e. 0.001 >P).
In other words, the ADP levels in the drug-treated rats 
were significantly lower than the control levels -g- and 
3 hours after treatment.
- xviil-
DOUBLE RANDOMIZATION - THREE TREATMENTS
(series 10)
The statistical design in this series was 
similar to that in series 9 (page xv) with the exception 
that there were three treatments at each of the three 
time intervals* The rats were, therefore, selected 
in groups of 3 of equal body weight. At each time 
interval the order of treatment of the 3 rats with the 
control solution (C), d-amphetamine solution (3)^ ) or
dl-phenmetrazine solution (Ep) was randomized using three 
3 x 3  latin squares. In order that a direct comparison 
could be made between the values obtained after each of 
these treatments at the three different time intervals 
(T^, Tp & T^), the order in which the groups of three was
done was randomized using three 3 x 3  latin squares.
Thus the following statistical design was obtained:
^2 (C Dg) (C Dg) ^3 (Dg 0
^ 3
Dg C) (Dg C Di) (Dl Dg C)
'^1
(Dg C (C D2) ^2 (Dl Dg C)
(Dg C Tg (D]^  C Dg) Tj (Dl Dg C) ;
Tj (C Dg) Il (Dl Dg C) Tg (Dg Dl 0)
Tg (C Dg D^) (Dg 0 Dl) Tl (0 Dl Dg)
(Dl Dg 0) "3 (C Dl Dg) ^2 (Dg Dl C)
''3 (Dg C D^) ^2 (C Dg Dl) (C Dl Dg)
:^ 2 (Dl 0 Dg) (Dg C h ) ^3 (Dl Dg C)
- X1X'“-
Each. set of values obtained (i.e., inorganic phosphate,
phosphocreatine, AIvIP, AEP, ATP, AMP + AEP + ATP and
ATP/AEP ratio) was analyzed in the following six ways
for significance.
1. All of the T^ values form three 3 x 3  latin squares
and were analyzed in the manner previously described
for such a design to find out if there was any
difference between C^, Ep at this time
interval.
2. All of the Tp values were similarly analyzed to find
out if there was any difference betv/een 0, E^ or E2
at this time interval.
3. All of the T^ values were similarly analyzed to find
out if there was any difference between C, E^ or E2
at this time interval.
4 . Since T^, T2 and T^ were also randomized using 
three 3 x 3  latin squares, all of the control 
values may, be taken and analyzed in the normal v/ay 
to find out if there was any difference between the 
control values at the three different time intervals
5 . Similarly, all of the E^ values were analyzed to
find out if there was any difference between the
values at the three different time intervals.
6. Similarly, all of the E2 values were analyzed to
find out if there was any difference between the
values at the three different time intervals.
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